Phosphatidylcholine	O
hydrolysis	O
activates	O
NF-kappa	B-protein
B	I-protein
and	O
increases	O
human	O
immunodeficiency	O
virus	O
replication	O
in	O
human	B-cell_type
monocytes	I-cell_type
and	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

We	O
have	O
tested	O
whether	O
breakdown	O
of	O
phosphatidylcholine	O
(	O
PC	O
)	O
initiated	O
by	O
exogenous	O
addition	O
of	O
a	O
PC-specific	B-protein
phospholipase	I-protein
C	I-protein
(	O
PC-PLC	B-protein
)	O
from	O
Bacillus	O
cereus	O
or	O
by	O
endogenous	O
overexpression	O
of	O
PC-PLC	B-protein
induces	O
functional	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
and	O
increases	O
human	B-DNA
immunodeficiency	I-DNA
virus	I-DNA
(	I-DNA
HIV	I-DNA
)	I-DNA
enhancer	I-DNA
activity	O
.	O

PC-PLC-activated	O
hydrolysis	O
of	O
PC	O
was	O
found	O
to	O
induce	O
bona	O
fide	O
p50/p65	B-protein
NF-kappa	I-protein
B	I-protein
binding	O
activity	O
in	O
three	O
different	O
cell	B-cell_line
lines	I-cell_line
of	O
human	O
or	O
murine	O
origin	O
.	O

No	O
significant	O
changes	O
in	O
the	O
turnover	O
of	O
other	O
cellular	O
phospholipids	O
were	O
detected	O
in	O
PC-PLC-treated	B-cell_line
cells	I-cell_line
.	O

Induction	O
of	O
NF-kappa	B-protein
B	I-protein
by	O
PC-PLC	B-protein
did	O
not	O
depend	O
on	O
de	O
novo	O
synthesis	O
of	O
proteins	O
or	O
autocrine	O
secretion	O
of	O
either	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
or	O
interleukin	B-protein
1	I-protein
.	O

In	O
human	B-cell_line
monocytic	I-cell_line
and	I-cell_line
lymphoblastoid	I-cell_line
T-cell	I-cell_line
lines	I-cell_line
,	O
induction	O
of	O
NF-kappa	B-protein
B	I-protein
by	O
PC-PLC	B-protein
resulted	O
in	O
clear	O
induction	O
of	O
luciferase	B-protein
expression	O
vectors	O
placed	O
under	O
the	O
control	O
of	O
synthetic	B-DNA
kappa	I-DNA
B	I-DNA
enhancers	I-DNA
or	O
wild	O
type	O
,	O
but	O
not	O
kappa	O
B-mutated	O
,	O
HIV	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
constructs	I-DNA
.	O

HIV	O
replication	O
was	O
increased	O
by	O
PC-PLC	B-protein
in	O
chronically	O
infected	O
monocytes	B-cell_type
and	O
T	O
lymphocytes	B-cell_type
.	O

NF-kappa	O
B	O
activation	O
promoted	O
by	O
addition	O
of	O
exogenous	B-protein
PC-PLC	I-protein
correlated	O
with	O
an	O
intense	O
production	O
of	O
diacylglycerol	O
.	O

However	O
,	O
addition	O
of	O
a	O
phosphatidylinositol-specific	B-protein
PLC	I-protein
from	O
B.cereus	O
also	O
induced	O
diacylglycerol	O
but	O
did	O
not	O
activate	O
kappa	B-protein
B	I-protein
enhancer-directed	I-protein
vectors	I-protein
.	O

PC-PLC-induced	O
NF-kappa	O
B	O
activation	O
could	O
not	O
be	O
blocked	O
by	O
a	O
specific	O
inhibitor	O
of	O
phorbol	B-protein
ester-inducible	I-protein
protein	I-protein
kinases	I-protein
C	I-protein
.	O

These	O
results	O
indicate	O
that	O
a	O
cellular	O
transduction	O
pathway	O
,	O
dependent	O
on	O
specific	O
PC	O
breakdown	O
,	O
is	O
functional	O
in	O
T	B-cell_type
lymphocytes	I-cell_type
and	O
monocytes	B-cell_type
and	O
may	O
be	O
used	O
by	O
various	O
transmembrane	O
receptors	O
to	O
activate	O
HIV	O
transcription	O
through	O
NF-kappa	O
B-dependent	O
induction	O
of	O
the	O
HIV	B-DNA
enhancer	I-DNA
.	O

Journat	NULL
or	NULL
ViroLogy	NULL
,	NULL
Nov.	NULL
1993	NULL
,	NULL
p.	NULL
6596-6604	NULL
0022-538	NULL
X/93/116596-09	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1993	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

67	NULL
,	NULL
No	NULL
.	NULL

11	NULL
Phosphatidylcholine	NULL
Hydrolysis	NULL
Activates	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Increases	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Replication	NULL
in	NULL
Human	NULL
Monocytes	NULL
and	NULL
T	NULL
Lymphocytes	NULL
FERNANDO	NULL
ARENZANA-SEISDEDOS	NULL
,	NULL
'*	NULL
BELEN	NULL
FERNANDEZ	NULL
,	NULL
!	NULL

ISABEL	NULL
DOMINGUEZ	NULL
,	NULL
JEAN	NULL
MARC	NULL
JACQUE	NULL
,	NULL
'	NULL
DOMINIQUE	NULL
THOMAS	NULL
,	NULL
``	NULL
MARIA	NULL
TERESA	NULL
DIAZ-MECO	NULL
,	NULL
*	NULL
JORGE	NULL
MOSCAT	NULL
,	NULL
``	NULL
anp	NULL
JEAN	NULL
LOUIS	NULL
VIRELIZIER	NULL
'	NULL
Unite	NULL
d	NULL
'Immunologie	NULL
Virale	NULL
,	NULL
Institut	NULL
Pasteur	NULL
,	NULL
28	NULL
rue	NULL
du	NULL
Dr.	NULL
Roux	NULL
,	NULL
75724	NULL
Paris	NULL
Cedex	NULL
15	NULL
,	NULL
France	NULL
,	NULL
``	NULL
and	NULL
Centro	NULL
de	NULL
Biologia	NULL
Molecular	NULL
,	NULL
Consejo	NULL
Superior	NULL
de	NULL
Investigaciones	NULL
Cientificas-UAM	NULL
,	NULL
Canto	NULL
Blanco	NULL
,	NULL
24049	NULL
Madrid	NULL
,	NULL
Spain	NULL
Received	NULL
11	NULL
May	NULL
1993/Accepted	NULL
3	NULL
August	NULL
1993	NULL
We	NULL
have	NULL
tested	NULL
whether	NULL
breakdown	NULL
of	NULL
phosphatidylcholine	NULL
(	NULL
PC	NULL
)	NULL
initiated	NULL
by	NULL
exogenous	NULL
addition	NULL
of	NULL
a	NULL
PC-specific	NULL
phospholipase	NULL
C	NULL
(	NULL
PC-PLC	NULL
)	NULL
from	NULL
Bacillus	NULL
cereus	NULL
or	NULL
by	NULL
endogenous	NULL
overexpression	NULL
of	NULL
PC-PLC	NULL
induces	NULL
functional	NULL
activation	NULL
of	NULL
NF-KB	NULL
and	NULL
increases	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
enhancer	NULL
activity	NULL
.	NULL

PC-PLC-activated	NULL
hydrolysis	NULL
of	NULL
PC	NULL
was	NULL
found	NULL
to	NULL
induce	NULL
bona	NULL
fide	NULL
p50/p65	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
three	NULL
different	NULL
cell	NULL
lines	NULL
of	NULL
human	NULL
or	NULL
murine	NULL
origin	NULL
.	NULL

No	NULL
significant	NULL
changes	NULL
in	NULL
the	NULL
turnover	NULL
of	NULL
other	NULL
cellular	NULL
phospholipids	NULL
were	NULL
detected	NULL
in	NULL
PC-PLC-treated	NULL
cells	NULL
.	NULL

Induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
PC-PLC	NULL
did	NULL
not	NULL
depend	NULL
on	NULL
de	NULL
novo	NULL
synthesis	NULL
of	NULL
proteins	NULL
or	NULL
autocrine	NULL
secretion	NULL
of	NULL
either	NULL
tumor	NULL
necrosis	NULL
factor	NULL
or	NULL
interleukin	NULL
1	NULL
.	NULL

In	NULL
human	NULL
monocytic	NULL
and	NULL
lymphoblastoid	NULL
T-cell	NULL
lines	NULL
,	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
PC-PLC	NULL
resulted	NULL
in	NULL
clear	NULL
induction	NULL
of	NULL
luciferase	NULL
expression	NULL
vectors	NULL
placed	NULL
under	NULL
the	NULL
control	NULL
of	NULL
synthetic	NULL
«	NULL
B	NULL
enhancers	NULL
or	NULL
wild	NULL
type	NULL
,	NULL
but	NULL
not	NULL
«	NULL
B-mutated	NULL
,	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
constructs	NULL
.	NULL

HIV	NULL
replication	NULL
was	NULL
increased	NULL
by	NULL
PC-PLC	NULL
in	NULL
chronically	NULL
infected	NULL
monocytes	NULL
and	NULL
T	NULL
lymphocytes	NULL
.	NULL

NF-KB	NULL
activation	NULL
promoted	NULL
by	NULL
addition	NULL
of	NULL
exogenous	NULL
PC-PLC	NULL
correlated	NULL
with	NULL
an	NULL
intense	NULL
production	NULL
of	NULL
diacylglycerol	NULL
.	NULL

However	NULL
,	NULL
addition	NULL
of	NULL
a	NULL
phosphatidylinositol-specific	NULL
PLC	NULL
from	NULL
B.	NULL
cereus	NULL
also	NULL
induced	NULL
diacylglycerol	NULL
but	NULL
did	NULL
not	NULL
activate	NULL
«	NULL
B	NULL
enhancer-directed	NULL
vectors	NULL
.	NULL

PC-PLC-induced	NULL
NF-KB	NULL
activation	NULL
could	NULL
not	NULL
be	NULL
blocked	NULL
by	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
phorbol	NULL
ester-inducible	NULL
protein	NULL
kinases	NULL
C.	NULL
These	NULL
results	NULL
indicate	NULL
that	NULL
a	NULL
cellular	NULL
transduction	NULL
pathway	NULL
,	NULL
dependent	NULL
on	NULL
specific	NULL
PC	NULL
breakdown	NULL
,	NULL
is	NULL
functional	NULL
in	NULL
T	NULL
lymphocytes	NULL
and	NULL
monocytes	NULL
and	NULL
may	NULL
be	NULL
used	NULL
by	NULL
various	NULL
transmembrane	NULL
receptors	NULL
to	NULL
activate	NULL
HIV	NULL
transcription	NULL
through	NULL
NF-	NULL
«	NULL
B-dependent	NULL
induction	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
.	NULL

Initiation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
genome	NULL
transcription	NULL
,	NULL
after	NULL
integration	NULL
of	NULL
the	NULL
HIV	NULL
provirus	NULL
into	NULL
host	NULL
cell	NULL
DNA	NULL
,	NULL
appears	NULL
to	NULL
be	NULL
determined	NULL
by	NULL
transcription	NULL
factors	NULL
interacting	NULL
with	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Transcriptional	NULL
activation	NULL
of	NULL
the	NULL
LTR	NULL
depends	NULL
largely	NULL
on	NULL
a	NULL
major	NULL
enhancer	NULL
made	NULL
of	NULL
two	NULL
directly	NULL
repeated	NULL
sequences	NULL
able	NULL
to	NULL
respond	NULL
to	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
25	NULL
,	NULL
33	NULL
)	NULL
.	NULL

For	NULL
this	NULL
event	NULL
to	NULL
occur	NULL
and	NULL
HIV	NULL
transcription	NULL
to	NULL
be	NULL
initiated	NULL
,	NULL
NF-kB	NULL
,	NULL
usually	NULL
associating	NULL
pSO	NULL
(	NULL
18	NULL
)	NULL
and	NULL
p65	NULL
(	NULL
30	NULL
)	NULL
subunits	NULL
,	NULL
must	NULL
be	NULL
activated	NULL
and	NULL
translocated	NULL
into	NULL
the	NULL
nucleus	NULL
from	NULL
the	NULL
cyto-plasm	NULL
,	NULL
where	NULL
it	NULL
is	NULL
normally	NULL
retained	NULL
by	NULL
interaction	NULL
with	NULL
inhibitory	NULL
proteins	NULL
named	NULL
IxB	NULL
(	NULL
3	NULL
,	NULL
22	NULL
)	NULL
.	NULL

The	NULL
biochemical	NULL
events	NULL
leading	NULL
to	NULL
this	NULL
critical	NULL
dissociation	NULL
of	NULL
NF-kB	NULL
heterodimers	NULL
from	NULL
IxB	NULL
have	NULL
not	NULL
been	NULL
elucidated	NULL
.	NULL

Induction	NULL
of	NULL
transcriptionally	NULL
active	NULL
NF-kB	NULL
complexes	NULL
occurs	NULL
after	NULL
cellular	NULL
activation	NULL
either	NULL
following	NULL
physiological	NULL
signalling	NULL
engaging	NULL
the	NULL
CD3-T-cell	NULL
receptor	NULL
complex	NULL
in	NULL
T	NULL
lymphocytes	NULL
,	NULL
in	NULL
particular	NULL
antigen	NULL
recognition	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
and	NULL
anti-CD3	NULL
antibodies	NULL
(	NULL
35	NULL
)	NULL
,	NULL
or	NULL
following	NULL
stimulation	NULL
with	NULL
artificial	NULL
inducers	NULL
such	NULL
as	NULL
phorbol	NULL
esters	NULL
in	NULL
both	NULL
T	NULL
lymphocytes	NULL
and	NULL
monocyte/macrophages	NULL
,	NULL
the	NULL
two	NULL
main	NULL
targets	NULL
of	NULL
HIV	NULL
infection	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
type	NULL
C	NULL
protein	NULL
kinases	NULL
(	NULL
PKC	NULL
)	NULL
in	NULL
T	NULL
lymphocytes	NULL
blocks	NULL
induction	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
by	NULL
either	NULL
CD3	NULL
antibodies	NULL
or	NULL
phorbol	NULL
esters	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
assumed	NULL
that	NULL
in	NULL
all	NULL
these	NULL
cases	NULL
,	NULL
NF-kB	NULL
induction	NULL
depends	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
PKC	NULL
.	NULL

This	NULL
is	NULL
obviously	NULL
the	NULL
case	NULL
when	NULL
phorbol	NULL
esters	NULL
are	NULL
used	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

6596	NULL
as	NULL
the	NULL
inducer	NULL
,	NULL
since	NULL
some	NULL
PKC	NULL
isoforms	NULL
,	NULL
such	NULL
as	NULL
the	NULL
calcium-dependent	NULL
«	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
PKCs	NULL
,	NULL
are	NULL
intracellular	NULL
targets	NULL
for	NULL
phorbol	NULL
esters	NULL
.	NULL

Furthermore	NULL
,	NULL
direct	NULL
demonstration	NULL
that	NULL
purified	NULL
PKC	NULL
indeed	NULL
phosphorylates	NULL
IxB	NULL
has	NULL
been	NULL
obtained	NULL
with	NULL
cell	NULL
lysates	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
intracellular	NULL
messenger	NULL
which	NULL
links	NULL
membrane	NULL
signals	NULL
to	NULL
PKC	NULL
is	NULL
diacylglycerol	NULL
(	NULL
DAG	NULL
)	NULL
.	NULL

An	NULL
important	NULL
but	NULL
transient	NULL
source	NULL
of	NULL
DAG	NULL
is	NULL
the	NULL
hydrolysis	NULL
of	NULL
phos-phatidylinositol	NULL
(	NULL
PI	NULL
)	NULL
which	NULL
takes	NULL
place	NULL
following	NULL
activation	NULL
signals	NULL
through	NULL
specific	NULL
membrane	NULL
receptors	NULL
in	NULL
many	NULL
cell	NULL
types	NULL
,	NULL
especially	NULL
T	NULL
lymphocytes	NULL
(	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
hydrolysis	NULL
of	NULL
phosphatidylcholine	NULL
(	NULL
PC	NULL
)	NULL
is	NULL
now	NULL
largely	NULL
accepted	NULL
to	NULL
account	NULL
for	NULL
the	NULL
production	NULL
of	NULL
the	NULL
sustained	NULL
amounts	NULL
of	NULL
DAG	NULL
detected	NULL
in	NULL
activated	NULL
cells	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
DAG	NULL
derived	NULL
from	NULL
PI	NULL
hydrolysis	NULL
(	NULL
11	NULL
,	NULL
23	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
declines	NULL
within	NULL
minutes	NULL
after	NULL
the	NULL
onset	NULL
of	NULL
cell	NULL
activation	NULL
.	NULL

The	NULL
sustained	NULL
production	NULL
of	NULL
DAG	NULL
generated	NULL
after	NULL
specific	NULL
breakdown	NULL
of	NULL
PC	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
DNA	NULL
synthesis	NULL
in	NULL
fibroblasts	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
induction	NULL
of	NULL
the	NULL
interleukin	NULL
2Ra	NULL
(	NULL
IL-2Ra	NULL
«	NULL
)	NULL
gene	NULL
and	NULL
DNA	NULL
synthesis	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
require	NULL
the	NULL
prolonged	NULL
presence	NULL
of	NULL
high	NULL
levels	NULL
of	NULL
DAG	NULL
(	NULL
4	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
a	NULL
sustained	NULL
production	NULL
of	NULL
this	NULL
messenger	NULL
is	NULL
necessary	NULL
to	NULL
maintain	NULL
transcription	NULL
of	NULL
inducible	NULL
genes	NULL
involved	NULL
in	NULL
cell	NULL
activation	NULL
and	NULL
proliferation	NULL
.	NULL

Stimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
either	NULL
with	NULL
phorbol	NULL
esters	NULL
or	NULL
through	NULL
the	NULL
CD3-T-cell	NULL
receptor	NULL
activates	NULL
NF-kB	NULL
and	NULL
HIV	NULL
LTR	NULL
transcription	NULL
and	NULL
also	NULL
induces	NULL
breakdown	NULL
of	NULL
PC	NULL
,	NULL
with	NULL
generation	NULL
of	NULL
DAG	NULL
independently	NULL
of	NULL
PI	NULL
hydrolysis	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
activation	NULL
of	NULL
p21	NULL
ras	NULL
,	NULL
which	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
cell	NULL
activation	NULL
and	NULL
induces	NULL
PC	NULL
breakdown	NULL
and	NULL
DAG	NULL
formation	NULL
without	NULL
significant	NULL
modification	NULL
of	NULL
PI	NULL
metabolism	NULL
(	NULL
20	NULL
,	NULL
28	NULL
)	NULL
Vor	NULL
.	NULL

67	NULL
,	NULL
1993	NULL
transactivates	NULL
the	NULL
HIV	NULL
enhancer	NULL
in	NULL
human	NULL
cells	NULL
(	NULL
1a	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
recent	NULL
data	NULL
from	NULL
our	NULL
laboratory	NULL
now	NULL
directly	NULL
document	NULL
in	NULL
Xenopus	NULL
laevis	NULL
oocytes	NULL
a	NULL
cascade	NULL
of	NULL
transduction	NULL
events	NULL
involving	NULL
ras-induced	NULL
hydrolysis	NULL
of	NULL
PC	NULL
and	NULL
DAG	NULL
production	NULL
mediated	NULL
by	NULL
a	NULL
PC-specific	NULL
phospholipase	NULL
C	NULL
(	NULL
PC-PLC	NULL
)	NULL
(	NULL
10	NULL
)	NULL
.	NULL

This	NULL
was	NULL
shown	NULL
to	NULL
lead	NULL
to	NULL
both	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
and	NULL
enhanced	NULL
transcription	NULL
of	NULL
«	NULL
B-dependent	NULL
vectors	NULL
through	NULL
activation	NULL
of	NULL
the	NULL
zeta	NULL
isoform	NULL
of	NULL
PKC	NULL
(	NULL
PKC	NULL
{	NULL
)	NULL
,	NULL
a	NULL
calcium-independent	NULL
and	NULL
non-phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
-inducible	NULL
isotype	NULL
of	NULL
PKC	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Altogether	NULL
,	NULL
the	NULL
above-mentioned	NULL
data	NULL
indicate	NULL
that	NULL
,	NULL
in	NULL
human	NULL
monocytes	NULL
and	NULL
T	NULL
lymphocytes	NULL
,	NULL
the	NULL
two	NULL
types	NULL
of	NULL
target	NULL
cells	NULL
of	NULL
HIV	NULL
infection	NULL
,	NULL
phosphodiesterase-mediated	NULL
hydrolysis	NULL
of	NULL
PC	NULL
has	NULL
the	NULL
potential	NULL
to	NULL
be	NULL
a	NULL
major	NULL
activation	NULL
pathway	NULL
leading	NULL
to	NULL
induction	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B-binding	NULL
activity	NULL
and	NULL
transactivation	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
.	NULL

Using	NULL
cell	NULL
systems	NULL
relevant	NULL
to	NULL
HIV	NULL
pathogenesis	NULL
,	NULL
including	NULL
an	NULL
IL-2-dependent	NULL
T-cell	NULL
clone	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
specific	NULL
hydrolysis	NULL
of	NULL
PC	NULL
,	NULL
but	NULL
not	NULL
PI	NULL
,	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
bona	NULL
fide	NULL
NF-kB	NULL
and	NULL
enhances	NULL
HIV	NULL
enhancer	NULL
activity	NULL
independently	NULL
of	NULL
classical	NULL
,	NULL
phorbol	NULL
ester-inducible	NULL
PKC	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
show	NULL
that	NULL
increased	NULL
HIV	NULL
enhancer	NULL
activity	NULL
correlates	NULL
with	NULL
augmented	NULL
HIV	NULL
replication	NULL
in	NULL
chronically	NULL
infected	NULL
cells	NULL
treated	NULL
with	NULL
PC-PLC	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
.	NULL

J.	NULL
Jhan	NULL
is	NULL
a	NULL
human	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
derived	NULL
from	NULL
Jurkat	NULL
.	NULL

U937	NULL
is	NULL
a	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
.	NULL

U1	NULL
,	NULL
derived	NULL
from	NULL
U937	NULL
,	NULL
and	NULL
ACH2	NULL
,	NULL
derived	NULL
from	NULL
the	NULL
lymphoblastoid	NULL
T-cell	NULL
line	NULL
CEM	NULL
,	NULL
are	NULL
chronically	NULL
HIV-infected	NULL
cell	NULL
lines	NULL
.	NULL

NIH	NULL
3T3	NULL
cells	NULL
are	NULL
murine	NULL
fibroblasts	NULL
.	NULL

The	NULL
SPBenv	NULL
cell	NULL
line	NULL
was	NULL
obtained	NULL
by	NULL
infection	NULL
of	NULL
SPB21	NULL
cells	NULL
,	NULL
an	NULL
IL-2-dependent	NULL
CD4	NULL
*	NULL
T-cell	NULL
clone	NULL
(	NULL
15	NULL
)	NULL
,	NULL
with	NULL
a	NULL
recombinant	NULL
HIV	NULL
virus	NULL
carrying	NULL
an	NULL
amphotropic	NULL
envelope	NULL
.	NULL

The	NULL
recombinant	NULL
HIV	NULL
virus	NULL
was	NULL
obtained	NULL
by	NULL
cotransfecting	NULL
in	NULL
COS7	NULL
cells	NULL
a	NULL
noninfectious	NULL
HIV	NULL
provirus	NULL
,	NULL
a	NULL
derivative	NULL
of	NULL
HIV	NULL
R7/neo	NULL
(	NULL
12	NULL
)	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
M.	NULL
Feinberg	NULL
)	NULL
carrying	NULL
a	NULL
1,300-bp	NULL
deletion	NULL
from	NULL
nucleotide	NULL
5930	NULL
to	NULL
nucleotide	NULL
7210	NULL
in	NULL
the	NULL
envelope-coding	NULL
region	NULL
,	NULL
and	NULL
a	NULL
simian	NULL
virus	NULL
40	NULL
promoter-directed	NULL
expression	NULL
vector	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
M.	NULL
Alizon	NULL
)	NULL
of	NULL
the	NULL
amphotropic	NULL
4070A	NULL
Moloney	NULL
leukemia	NULL
virus	NULL
envelope	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Selection	NULL
of	NULL
infected	NULL
cells	NULL
was	NULL
obtained	NULL
by	NULL
using	NULL
a	NULL
neomycin	NULL
selectable	NULL
marker	NULL
located	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
(	NULL
nef	NULL
region	NULL
)	NULL
of	NULL
the	NULL
HIV	NULL
genome	NULL
.	NULL

Reagents	NULL
.	NULL

PC-PLC	NULL
from	NULL
Bacillus	NULL
cereus	NULL
was	NULL
either	NULL
obtained	NULL
and	NULL
purified	NULL
essentially	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
21	NULL
)	NULL
or	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
.	NULL

Pl-specific	NULL
phospholipase	NULL
C	NULL
(	NULL
PI-PLC	NULL
)	NULL
from	NULL
B.	NULL
cereus	NULL
was	NULL
purchased	NULL
from	NULL
Boehringer	NULL
Mannheim	NULL
.	NULL

Recombinant	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
W.	NULL
Fiers	NULL
.	NULL

The	NULL
bisindolyImaleimide	NULL
GF	NULL
109203X	NULL
(	NULL
GF	NULL
)	NULL
(	NULL
36	NULL
)	NULL
is	NULL
an	NULL
inhibitor	NULL
of	NULL
PKC	NULL
a	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
isoforms	NULL
and	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
J.	NULL
Kirilovsky	NULL
(	NULL
Glaxo	NULL
,	NULL
Les	NULL
Ulis	NULL
,	NULL
France	NULL
)	NULL
.	NULL

PMA	NULL
was	NULL
obtained	NULL
from	NULL
Sigma	NULL
.	NULL

Unless	NULL
indicated	NULL
otherwise	NULL
,	NULL
2	NULL
U	NULL
of	NULL
PC-PLC	NULL
per	NULL
ml	NULL
was	NULL
used	NULL
to	NULL
stimulate	NULL
cell	NULL
cultures	NULL
.	NULL

TNF	NULL
and	NULL
PMA	NULL
were	NULL
used	NULL
at	NULL
concentrations	NULL
of	NULL
340	NULL
IU/ml	NULL
and	NULL
20	NULL
ng/ml	NULL
,	NULL
respectively	NULL
.	NULL

Plasmids	NULL
.	NULL

Vector	NULL
HIV-LTR-Luc	NULL
(	NULL
2	NULL
)	NULL
consisted	NULL
of	NULL
the	NULL
Xhol	NULL
(	NULL
-640	NULL
)	NULL
-HindllII	NULL
(	NULL
+86	NULL
)	NULL
fragment	NULL
containing	NULL
the	NULL
U3	NULL
and	NULL
R	NULL
regions	NULL
of	NULL
the	NULL
HIV	NULL
type	NULL
1	NULL
strain	NULL
LAI	NULL
cloned	NULL
in	NULL
a	NULL
luciferase	NULL
expression	NULL
vector	NULL
(	NULL
pC-Luc	NULL
)	NULL
(	NULL
15	NULL
)	NULL
.	NULL

HIV-LTRA	NULL
«	NULL
B-Lue	NULL
(	NULL
2	NULL
)	NULL
was	NULL
obtained	NULL
by	NULL
insertion	NULL
into	NULL
the	NULL
pC-Luc	NULL
plasmid	NULL
of	NULL
the	NULL
«	NULL
kB	NULL
consensus	NULL
motif-deleted	NULL
Xhol-HindllI	NULL
fragment	NULL
of	NULL
the	NULL
LAI	NULL
LTR	NULL
.	NULL

The	NULL
kb-CONA-Luc	NULL
vector	NULL
derives	NULL
from	NULL
a	NULL
CONA-CAT	NULL
vector	NULL
described	NULL
by	NULL
Kimura	NULL
et	NULL
al	NULL
.	NULL

(	NULL
19	NULL
)	NULL
.	NULL

It	NULL
carries	NULL
a	NULL
luciferase	NULL
gene	NULL
(	NULL
pCLuc	NULL
)	NULL
placed	NULL
under	NULL
the	NULL
control	NULL
of	NULL
three	NULL
synthetic	NULL
copies	NULL
of	NULL
the	NULL
kB	NULL
consensus	NULL
of	NULL
the	NULL
immunoglobulin	NULL
«	NULL
-chain	NULL
PHOSPHATIDYLCHOLINE	NULL
HYDROLYSIS	NULL
INDUCES	NULL
HIV	NULL
REPLICATION	NULL
6597	NULL
promoter	NULL
cloned	NULL
in	NULL
the	NULL
BamHI	NULL
site	NULL
located	NULL
upstream	NULL
of	NULL
the	NULL
conalbumin	NULL
(	NULL
CONA	NULL
)	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

The	NULL
CONA-LUC	NULL
vector	NULL
is	NULL
identical	NULL
to	NULL
plasmid	NULL
kb-CONA-Luc	NULL
but	NULL
does	NULL
not	NULL
contain	NULL
the	NULL
«	NULL
kB	NULL
sequences	NULL
.	NULL

The	NULL
PC-PLC	NULL
expression	NULL
vector	NULL
,	NULL
pCMV-PLC	NULL
,	NULL
was	NULL
constructed	NULL
from	NULL
the	NULL
B.	NULL
cereus	NULL
PC-PLC	NULL
gene	NULL
.	NULL

It	NULL
carries	NULL
the	NULL
21-amino-acid	NULL
signal	NULL
peptide	NULL
of	NULL
the	NULL
Escherichia	NULL
coli	NULL
outer	NULL
membrane	NULL
protein	NULL
OmpA	NULL
.	NULL

This	NULL
construct	NULL
,	NULL
including	NULL
19	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
start	NULL
codon	NULL
,	NULL
was	NULL
then	NULL
inserted	NULL
into	NULL
the	NULL
mammalian	NULL
expression	NULL
vector	NULL
pRcCMV	NULL
(	NULL
pCMV	NULL
)	NULL
,	NULL
purchased	NULL
from	NULL
Invitrogene	NULL
.	NULL

Analysis	NULL
of	NULL
products	NULL
of	NULL
phospholipid	NULL
metabolism	NULL
.	NULL

For	NULL
determination	NULL
of	NULL
the	NULL
levels	NULL
of	NULL
different	NULL
phospholipids	NULL
,	NULL
cells	NULL
were	NULL
labelled	NULL
with	NULL
10	NULL
pCi	NULL
of	NULL
[	NULL
methy	NULL
!	NULL

-'*C	NULL
]	NULL
choline	NULL
for	NULL
PC	NULL
and	NULL
sphingomyelin	NULL
and	NULL
with	NULL
10	NULL
mCi	NULL
of	NULL
[	NULL
2-'*CJethan-1-olamine	NULL
for	NULL
phos-phatidylethanol	NULL
.	NULL

Identical	NULL
amounts	NULL
of	NULL
L-	NULL
[	NULL
U-'*CJserine	NULL
and	NULL
[	NULL
myo-2-*Hjlinositol	NULL
were	NULL
used	NULL
for	NULL
labelling	NULL
of	NULL
phosphatidylserine	NULL
or	NULL
polyphosphoinositides	NULL
,	NULL
respectively	NULL
.	NULL

After	NULL
induction	NULL
with	NULL
agonists	NULL
,	NULL
cell	NULL
cultures	NULL
were	NULL
treated	NULL
with	NULL
methanol	NULL
and	NULL
cell	NULL
extracts	NULL
were	NULL
fractionated	NULL
into	NULL
chloroform	NULL
and	NULL
aqueous	NULL
phases	NULL
.	NULL

Organic	NULL
phases	NULL
were	NULL
processed	NULL
essentially	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
21	NULL
)	NULL
.	NULL

For	NULL
determination	NULL
of	NULL
DAG	NULL
,	NULL
we	NULL
used	NULL
a	NULL
DAG	NULL
detection	NULL
kit	NULL
(	NULL
Amersham	NULL
)	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
in	NULL
terms	NULL
of	NULL
the	NULL
*P	NULL
label	NULL
incorporated	NULL
into	NULL
phosphatidic	NULL
acid	NULL
,	NULL
which	NULL
results	NULL
from	NULL
the	NULL
in	NULL
vitro	NULL
action	NULL
of	NULL
a	NULL
DAG	NULL
kinase	NULL
on	NULL
the	NULL
pool	NULL
of	NULL
cellular	NULL
DAG	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
amounts	NULL
of	NULL
radiolabelled	NULL
phosphatidic	NULL
acid	NULL
can	NULL
be	NULL
directly	NULL
correlated	NULL
to	NULL
the	NULL
levels	NULL
of	NULL
DAG	NULL
produced	NULL
by	NULL
cells	NULL
.	NULL

EMSA	NULL
.	NULL

Crude	NULL
nuclear	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
17	NULL
)	NULL
.	NULL

For	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
,	NULL
3	NULL
wg	NULL
of	NULL
protein	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
[	NULL
«	NULL
-°P	NULL
]	NULL
dCTP-labelled	NULL
double-stranded	NULL
oligodeoxynucleotides	NULL
corresponding	NULL
either	NULL
to	NULL
the	NULL
«	NULL
kB	NULL
motif	NULL
found	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
immunoglobulin	NULL
-chain	NULL
gene	NULL
or	NULL
to	NULL
the	NULL
tandem	NULL
of	NULL
kB	NULL
sequences	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
was	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
in	NULL
nondenaturing	NULL
5	NULL
%	NULL
polyacryl-amide	NULL
gels	NULL
.	NULL

In	NULL
DNA-binding	NULL
competition	NULL
assays	NULL
,	NULL
unlabelled	NULL
oligonucleotides	NULL
were	NULL
used	NULL
in	NULL
a	NULL
40-fold	NULL
molar	NULL
excess	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
corresponding	NULL
radiolabelled	NULL
probes	NULL
.	NULL

When	NULL
indicated	NULL
,	NULL
specific	NULL
polyclonal	NULL
rabbit	NULL
antibodies	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
R.	NULL
T.	NULL
Hay	NULL
)	NULL
generated	NULL
against	NULL
recombinant	NULL
p50	NULL
or	NULL
p65	NULL
)	NULL
or	NULL
a	NULL
C-terminal	NULL
peptide	NULL
of	NULL
c-Rel	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
I.	NULL
Verma	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
nuclear	NULL
extracts	NULL
for	NULL
10	NULL
min	NULL
before	NULL
addition	NULL
of	NULL
probes	NULL
.	NULL

Similarly	NULL
,	NULL
20	NULL
ng	NULL
of	NULL
recombinant	NULL
IxB/MAD-3	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
R.	NULL
T.	NULL
Hay	NULL
)	NULL
was	NULL
used	NULL
to	NULL
block	NULL
the	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
the	NULL
radiolabelled	NULL
oligonucleotides	NULL
.	NULL

Transfection	NULL
assays	NULL
.	NULL

Plasmids	NULL
were	NULL
transfected	NULL
in	NULL
U937	NULL
or	NULL
J.	NULL
Jhan	NULL
cells	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
.	NULL

Briefly	NULL
,	NULL
5	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
DNA	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
500	NULL
ug	NULL
of	NULL
DEAE-dextran	NULL
per	NULL
ml	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Subconfluent	NULL
NIH	NULL
3T3	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
technique	NULL
for	NULL
4	NULL
h.	NULL
After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
allowed	NULL
to	NULL
remain	NULL
in	NULL
culture	NULL
for	NULL
48	NULL
h	NULL
in	NULL
the	NULL
corresponding	NULL
culture	NULL
medium	NULL
enriched	NULL
either	NULL
with	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
in	NULL
the	NULL
case	NULL
of	NULL
U937	NULL
and	NULL
J.	NULL
Jhan	NULL
cells	NULL
or	NULL
with	NULL
0.2	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
for	NULL
NIH	NULL
3T3	NULL
fibroblasts	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
induced	NULL
with	NULL
the	NULL
different	NULL
stimuli	NULL
for	NULL
the	NULL
last	NULL
6	NULL
h	NULL
of	NULL
the	NULL
culture	NULL
period	NULL
.	NULL

For	NULL
detection	NULL
of	NULL
luciferase	NULL
activity	NULL
,	NULL
total	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
in	NULL
a	NULL
lysis	NULL
cell	NULL
buffer	NULL
,	NULL
and	NULL
samples	NULL
were	NULL
analyzed	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
15	NULL
)	NULL
,	NULL
in	NULL
a	NULL
luminometer	NULL
(	NULL
Berthold	NULL
,	NULL
Gosheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
in	NULL
terms	NULL
of	NULL
relative	NULL
luciferase	NULL
activity	NULL
units	NULL
,	NULL
calculated	NULL
as	NULL
(	NULL
light	NULL
emission	NULL
from	NULL
experimental	NULL
sample	NULL
-	NULL
light	NULL
emission	NULL
of	NULL
lysis	NULL
buffer	NULL
alone	NULL
)	NULL
/micrograms	NULL
of	NULL
cellular	NULL
protein	NULL
in	NULL
the	NULL
sample	NULL
.	NULL

Detection	NULL
of	NULL
p24	NULL
HIV	NULL
antigen	NULL
.	NULL

U1	NULL
or	NULL
ACH2	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
5	NULL
X	NULL
10°/ml	NULL
and	NULL
stimulated	NULL
for	NULL
24	NULL
h.	NULL
At	NULL
this	NULL
time	NULL
,	NULL
6598	NULL
ARENZANA-SEISDEDOS	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
Viroc	NULL
.	NULL

U937	NULL
J.JHAN	NULL
$	NULL
at	NULL
$	NULL
aP	NULL
$	NULL
ap	NULL
$	NULL
af	NULL
s	NULL
aS	NULL
aS	NULL
ab	NULL
AA	NULL
**	NULL
``	NULL
28	NULL
PAAS	NULL
mouc	NULL
.	NULL

-	NULL
-C	NULL
+C	NULL
_	NULL
x*	NULL
324	NULL
&	NULL
``	NULL
¢	NULL
_	NULL
_	NULL
*y	NULL
y*	NULL
¢	NULL
CHX	NULL
_	NULL
p	NULL
e	NULL
fe-	NULL
oft	NULL
o	NULL
fo	NULL
-~	NULL
+	NULL
-	NULL
'	NULL
f	NULL
-	NULL
$	NULL
%	NULL
-p	NULL
__	NULL
.	NULL

COMPET	NULL
.	NULL

\	NULL
__	NULL
_	NULL
-	NULL
--	NULL
-	NULL
WTWTWT	NULL
M	NULL
MM	NULL
0	NULL
__	NULL
-	NULL
-	NULL
-	NULL
_-	NULL
--	NULL
M	NULL
M	NULL
WTWT	NULL
Q0	NULL
w	NULL
8	NULL
#	NULL
#	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

PC-PLC	NULL
from	NULL
B.	NULL
cereus	NULL
induces	NULL
nuclear	NULL
«	NULL
B-binding	NULL
activity	NULL
on	NULL
human	NULL
monocytes	NULL
(	NULL
U937	NULL
)	NULL
and	NULL
T	NULL
lymphocytes	NULL
(	NULL
J.	NULL
Jhan	NULL
)	NULL
independently	NULL
of	NULL
de	NULL
novo	NULL
synthesis	NULL
of	NULL
proteins	NULL
.	NULL

Cells	NULL
were	NULL
preincubated	NULL
for	NULL
45	NULL
min	NULL
with	NULL
50	NULL
jg	NULL
of	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
then	NULL
they	NULL
were	NULL
stimulated	NULL
for	NULL
90	NULL
additional	NULL
min	NULL
with	NULL
PC-PLC	NULL
or	NULL
TNF	NULL
(	NULL
J.	NULL
Jhan	NULL
)	NULL
.	NULL

A	NULL
double-stranded	NULL
oligonucleotide	NULL
(	NULL
5-ACACAGGGACTTTCCGCTGGGGACTTTC	NULL
CAGGGA-3	NULL
'	NULL
)	NULL
containing	NULL
the	NULL
tandem	NULL
of	NULL
«	NULL
B	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
sequences	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
was	NULL
used	NULL
as	NULL
a	NULL
radiolabelled	NULL
probe	NULL
.	NULL

For	NULL
DNA-binding	NULL
competition	NULL
(	NULL
COMPET	NULL
.	NULL
)	NULL

,	NULL
unlabelled	NULL
oligonucleotides	NULL
(	NULL
WT	NULL
or	NULL
the	NULL
mutated	NULL
[	NULL
M	NULL
]	NULL
counterpart	NULL
[	NULL
5-ACACACTCACTTTCCGCTGCTCACTCC	NULL
AGGGA-3	NULL
'	NULL
]	NULL
)	NULL
were	NULL
used	NULL
in	NULL
a	NULL
40-fold	NULL
molar	NULL
excess	NULL
.	NULL

*	NULL
,	NULL
a	NULL
sample	NULL
containing	NULL
radiolabelled	NULL
probe	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

culture	NULL
supernatants	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
p24	NULL
viral	NULL
core	NULL
antigen	NULL
was	NULL
quantitated	NULL
by	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
DuPont/NEN	NULL
)	NULL
.	NULL

SPBenv-cells	NULL
were	NULL
starved	NULL
of	NULL
IL-2	NULL
for	NULL
18	NULL
h	NULL
before	NULL
induction	NULL
,	NULL
and	NULL
viral	NULL
antigen	NULL
was	NULL
evaluated	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
24-h-stimulated	NULL
cells	NULL
.	NULL

RESULTS	NULL
PC-PLC	NULL
induces	NULL
bona	NULL
fide	NULL
nuclear	NULL
«	NULL
B-binding	NULL
activity	NULL
in	NULL
human	NULL
monocytes	NULL
,	NULL
T	NULL
lymphocytes	NULL
,	NULL
and	NULL
murine	NULL
fibroblasts	NULL
.	NULL

Analysis	NULL
by	NULL
EMSA	NULL
of	NULL
crude	NULL
nuclear	NULL
extracts	NULL
from	NULL
monocytes	NULL
,	NULL
T	NULL
lymphocytes	NULL
,	NULL
or	NULL
murine	NULL
fibroblasts	NULL
incubated	NULL
with	NULL
PC-PLC	NULL
from	NULL
B.	NULL
cereus	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
specific	NULL
«	NULL
kB-binding	NULL
activity	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
treated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Specific	NULL
binding	NULL
of	NULL
NF-kB	NULL
proteins	NULL
from	NULL
either	NULL
U937	NULL
or	NULL
J.	NULL
Jhan	NULL
cells	NULL
to	NULL
the	NULL
radiolabelled	NULL
probes	NULL
(	NULL
HIV	NULL
enhancer	NULL
or	NULL
«	NULL
-chain	NULL
immunoglobulin	NULL
«	NULL
B	NULL
motifs	NULL
)	NULL
was	NULL
abrogated	NULL
by	NULL
addition	NULL
of	NULL
a	NULL
40-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
corresponding	NULL
unlabelled	NULL
,	NULL
wild-type	NULL
oligonucleotide	NULL
but	NULL
not	NULL
its	NULL
mutated	NULL
counterpart	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
J.	NULL
Jhan	NULL
cells	NULL
,	NULL
and	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
NIH	NULL
3T3	NULL
cells	NULL
)	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
TNF-treated	NULL
cells	NULL
were	NULL
introduced	NULL
as	NULL
a	NULL
source	NULL
of	NULL
control	NULL
bona	NULL
fide	NULL
NF-kB	NULL
.	NULL

Results	NULL
displayed	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
show	NULL
that	NULL
inhibition	NULL
of	NULL
protein	NULL
synthesis	NULL
did	NULL
not	NULL
block	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
by	NULL
PC-PLC	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
at	NULL
least	NULL
in	NULL
T	NULL
lymphocytes	NULL
,	NULL
stimulation	NULL
of	NULL
cycloheximide-treated	NULL
cells	NULL
with	NULL
either	NULL
PC-PLC	NULL
or	NULL
TNF	NULL
resulted	NULL
in	NULL
increased	NULL
induction	NULL
of	NULL
NF-kB	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
J.	NULL
Jhan	NULL
cells	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
characterize	NULL
the	NULL
components	NULL
of	NULL
the	NULL
kB-retarded	NULL
complexes	NULL
induced	NULL
by	NULL
PC-PLC	NULL
,	NULL
we	NULL
preincubated	NULL
nuclear	NULL
extracts	NULL
from	NULL
U937	NULL
cells	NULL
with	NULL
either	NULL
recombinant	NULL
IxB/MAD3	NULL
or	NULL
rabbit	NULL
specific	NULL
antisera	NULL
directed	NULL
against	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
or	NULL
c-Rel	NULL
.	NULL

Either	NULL
anti-p50	NULL
or	NULL
anti-p65	NULL
antibodies	NULL
detect	NULL
single	NULL
bands	NULL
in	NULL
Western	NULL
immunoblot	NULL
analysis	NULL
of	NULL
cytoplasmic	NULL
extracts	NULL
from	NULL
U937	NULL
cells	NULL
,	NULL
corresponding	NULL
in	NULL
apparent	NULL
molecular	NULL
mass	NULL
to	NULL
proteins	NULL
of	NULL
50	NULL
and	NULL
65	NULL
kDa	NULL
,	NULL
respectively	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
in	NULL
the	NULL
complexes	NULL
induced	NULL
by	NULL
PC-PLC	NULL
was	NULL
demonstrated	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
U937	NULL
cells	NULL
)	NULL
,	NULL
as	NULL
an	NULL
anti-p50	NULL
antibody	NULL
,	NULL
but	NULL
not	NULL
a	NULL
preimmune	NULL
rabbit	NULL
serum	NULL
,	NULL
greatly	NULL
impaired	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
and	NULL
induced	NULL
the	NULL
up-shifting	NULL
of	NULL
the	NULL
kB-binding	NULL
activity	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
addition	NULL
of	NULL
p50	NULL
antiserum	NULL
equally	NULL
blocked	NULL
the	NULL
formation	NULL
of	NULL
both	NULL
the	NULL
more	NULL
slowly	NULL
and	NULL
the	NULL
faster-migrating	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
U937	NULL
cells	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Fig	NULL
.	NULL

2	NULL
shows	NULL
that	NULL
incubation	NULL
of	NULL
PC-PLC-induced	NULL
U937	NULL
nuclear	NULL
extracts	NULL
with	NULL
anti-p65	NULL
antiserum	NULL
,	NULL
but	NULL
not	NULL
with	NULL
an	NULL
anti-c-Rel	NULL
antiserum	NULL
,	NULL
dramatically	NULL
retarded	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
more	NULL
slowly	NULL
migrating	NULL
complex	NULL
but	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
faster-migrating	NULL
complex	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
demonstrate	NULL
that	NULL
two	NULL
«	NULL
B-binding	NULL
activities	NULL
mainly	NULL
composed	NULL
of	NULL
homodimeric	NULL
p50	NULL
(	NULL
lower	NULL
arrowhead	NULL
)	NULL
or	NULL
p50/p65	NULL
(	NULL
upper	NULL
arrowhead	NULL
)	NULL
complexes	NULL
were	NULL
induced	NULL
in	NULL
U937	NULL
cells	NULL
by	NULL
PC-PLC	NULL
.	NULL

This	NULL
conclusion	NULL
is	NULL
reinforced	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
recombinant	NULL
IxB	NULL
to	NULL
prevent	NULL
binding	NULL
of	NULL
heterodimeric	NULL
p50/p65	NULL
complexes	NULL
in	NULL
the	NULL
three	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
without	NULL
affecting	NULL
the	NULL
formation	NULL
of	NULL
DNA-binding	NULL
complexes	NULL
formed	NULL
by	NULL
p50	NULL
homodimers	NULL
(	NULL
lower	NULL
arrowhead	NULL
)	NULL
detected	NULL
in	NULL
both	NULL
U937	NULL
and	NULL
NIH	NULL
3T3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

PC	NULL
hydrolysis	NULL
induces	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
and	NULL
HIV	NULL
replication	NULL
in	NULL
chronically	NULL
infected	NULL
cell	NULL
lines	NULL
.	NULL

To	NULL
demonstrate	NULL
that	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
induced	NULL
by	NULL
PC-PLC	NULL
in	NULL
U937	NULL
or	NULL
J.	NULL
Jhan	NULL
cells	NULL
were	NULL
functionally	NULL
active	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
transcription	NULL
activity	NULL
of	NULL
transfected	NULL
luciferase	NULL
expression	NULL
vectors	NULL
placed	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
.	NULL

After	NULL
42	NULL
h	NULL
of	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
6	NULL
additional	NULL
h	NULL
with	NULL
PC-PLC	NULL
,	NULL
and	NULL
then	NULL
luciferase	NULL
activity	NULL
was	NULL
evaluated	NULL
in	NULL
whole-cell	NULL
lysates	NULL
.	NULL

TNF	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
of	NULL
HIV	NULL
LTR	NULL
transactivation	NULL
.	NULL

Results	NULL
of	NULL
transient	NULL
transfection	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
show	NULL
a	NULL
clear	NULL
induction	NULL
of	NULL
HIV	NULL
LTR	NULL
activity	NULL
and	NULL
demonstrate	NULL
that	NULL
the	NULL
enhancer	NULL
sequences	NULL
mediated	NULL
the	NULL
transactivation	NULL
effect	NULL
promoted	NULL
by	NULL
PC-PLC	NULL
inasmuch	NULL
as	NULL
deletion	NULL
of	NULL
the	NULL
tandem	NULL
of	NULL
«	NULL
kB	NULL
motifs	NULL
abolished	NULL
the	NULL
LTR	NULL
responses	NULL
VoL	NULL
.	NULL

67	NULL
.	NULL

1993	NULL
PHOSPHATIDYLCHOLINE	NULL
HYDROLYSIS	NULL
INDUCES	NULL
HIV	NULL
REPLICATION	NULL
6599	NULL
u937	NULL
NIH3T3	NULL
J.JHAN	NULL
FPESSSASS	NULL
.a	NULL
``	NULL
C	NULL
<	NULL
<	NULL
``	NULL
NAS	NULL
mDUC	NULL
.	NULL

-	NULL
C	NULL
_	NULL
mpuc	NULL
.	NULL

-	NULL
¥	NULL
#	NULL
-	NULL
#	NULL
#	NULL
-q	NULL
-	NULL
4C	NULL
<	NULL
<	NULL
ANTI	NULL
.	NULL

--	NULL
&	NULL
&	NULL
&	NULL
p__	NULL
_	NULL
_	NULL
COMPET	NULL
-	NULL
--	NULL
--	NULL
-	NULL
wTwrwr	NULL
oy	NULL
PKC-INH	NULL
,	NULL
--	NULL
--	NULL
-	NULL
--	NULL
p	NULL
p	NULL
IRB	NULL
-	NULL
--	NULL
4+	NULL
++	NULL
--	NULL
-	NULL
=	NULL
IkKB	NULL
|	NULL
___	NULL
_c	NULL
c	NULL
cg	NULL
_	NULL
-	NULL
UUU	NULL
WH	NULL
.	NULL

uH	NULL
l	NULL
>	NULL
Mb	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

EMSA	NULL
characterization	NULL
of	NULL
proteins	NULL
integrated	NULL
in	NULL
the	NULL
kB-binding	NULL
complexes	NULL
induced	NULL
by	NULL
exogenous	NULL
PC-PLC	NULL
and	NULL
independence	NULL
of	NULL
their	NULL
induction	NULL
from	NULL
PKC	NULL
a	NULL
,	NULL
.	NULL

B	NULL
,	NULL
and	NULL
y.	NULL
U937	NULL
and	NULL
J.	NULL
Jhan	NULL
cells	NULL
were	NULL
stimulated	NULL
(	NULL
INDUC	NULL
.	NULL
)	NULL

for	NULL
1	NULL
h	NULL
with	NULL
2	NULL
U	NULL
of	NULL
PC-PLC	NULL
per	NULL
ml	NULL
.	NULL

One	NULL
unit	NULL
of	NULL
PC-PLC	NULL
per	NULL
ml	NULL
was	NULL
used	NULL
to	NULL
induce	NULL
NIH	NULL
3T3	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
U937	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
10	NULL
min	NULL
with	NULL
specific	NULL
anti-p50	NULL
,	NULL
anti-p65	NULL
,	NULL
or	NULL
anti-c-Rel	NULL
rabbit	NULL
antibodies	NULL
(	NULL
ANTIB	NULL
.	NULL
)	NULL

before	NULL
addition	NULL
of	NULL
the	NULL
radiolabelled	NULL
probes	NULL
.	NULL

A	NULL
rabbit	NULL
preimmune	NULL
(	NULL
pre	NULL
.	NULL
)	NULL

serum	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
45	NULL
min	NULL
with	NULL
2.5	NULL
wM	NULL
PKC	NULL
inhibitor	NULL
GF	NULL
before	NULL
stimulation	NULL
with	NULL
PC-PLC	NULL
.	NULL

To	NULL
prevent	NULL
the	NULL
formation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
,	NULL
20	NULL
ng	NULL
of	NULL
recombinant	NULL
IxB/MAD3	NULL
(	NULL
IxB	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
nuclear	NULL
extracts	NULL
from	NULL
U937	NULL
,	NULL
J.	NULL
Jhan	NULL
,	NULL
or	NULL
NIH	NULL
3T3	NULL
cells	NULL
.	NULL

For	NULL
both	NULL
U937	NULL
and	NULL
J.	NULL
Jhan	NULL
nuclear	NULL
extracts	NULL
,	NULL
the	NULL
«	NULL
B	NULL
wild-type	NULL
sequence	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

For	NULL
NIH	NULL
3T3	NULL
extracts	NULL
,	NULL
a	NULL
synthetic	NULL
oligonucleotide	NULL
with	NULL
the	NULL
xB	NULL
motif	NULL
from	NULL
the	NULL
immunoglobulin	NULL
«	NULL
-chain	NULL
promoter	NULL
was	NULL
used	NULL
as	NULL
a	NULL
radiolabelled	NULL
probe	NULL
.	NULL

Specific	NULL
inhibition	NULL
(	NULL
COMPET	NULL
.	NULL
)	NULL

of	NULL
DNA	NULL
binding	NULL
by	NULL
unlabelled	NULL
oligonucleotides	NULL
was	NULL
performed	NULL
(	NULL
NIH	NULL
3T3	NULL
and	NULL
J.	NULL
Jhan	NULL
cells	NULL
)	NULL
by	NULL
adding	NULL
a	NULL
40-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
corresponding	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
oligonucleotide	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
heterodimeric	NULL
p50/p65	NULL
complexes	NULL
and	NULL
homodimeric	NULL
p50	NULL
complexes	NULL
are	NULL
indicated	NULL
(	NULL
upper	NULL
and	NULL
lower	NULL
arrowheads	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

to	NULL
either	NULL
PC-PLC	NULL
or	NULL
TNF	NULL
.	NULL

Maximal	NULL
induction	NULL
was	NULL
usually	NULL
obtained	NULL
at	NULL
PC-PLC	NULL
concentrations	NULL
of	NULL
1	NULL
to	NULL
2	NULL
U/ml	NULL
,	NULL
although	NULL
concentrations	NULL
as	NULL
low	NULL
as	NULL
0.1	NULL
U/ml	NULL
induced	NULL
detectable	NULL
transactivation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
NIH	NULL
3T3	NULL
fibroblasts	NULL
by	NULL
using	NULL
the	NULL
«	NULL
B-CONA-Luc	NULL
vector	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
the	NULL
HIV	NULL
LTR	NULL
transactivation	NULL
induced	NULL
by	NULL
PC-PLC	NULL
correlated	NULL
with	NULL
its	NULL
PC-hydrolyzing	NULL
activity	NULL
and	NULL
DAG	NULL
production	NULL
(	NULL
Table	NULL
1	NULL
and	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
obtain	NULL
further	NULL
evidence	NULL
for	NULL
the	NULL
specificity	NULL
of	NULL
this	NULL
effect	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
effects	NULL
of	NULL
PI-PLC	NULL
and	NULL
PC-PLC	NULL
,	NULL
both	NULL
obtained	NULL
from	NULL
B.	NULL
cereus	NULL
,	NULL
on	NULL
U937	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
kB-CONA-Luc	NULL
vector	NULL
.	NULL

Results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4b	NULL
indicate	NULL
that	NULL
PC-PLC	NULL
,	NULL
but	NULL
not	NULL
PI-PLC	NULL
,	NULL
was	NULL
able	NULL
to	NULL
increase	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
kB-directed	NULL
vector	NULL
.	NULL

The	NULL
inability	NULL
of	NULL
PI-PLC	NULL
to	NULL
enhance	NULL
the	NULL
activity	NULL
of	NULL
kB	NULL
enhancers	NULL
contrasted	NULL
with	NULL
its	NULL
capacity	NULL
to	NULL
induce	NULL
a	NULL
clear	NULL
increase	NULL
of	NULL
DAG	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
.	NULL

The	NULL
above	NULL
results	NULL
,	NULL
obtained	NULL
with	NULL
exogenously	NULL
added	NULL
PC-PLC	NULL
,	NULL
were	NULL
confirmed	NULL
in	NULL
experiments	NULL
whose	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
by	NULL
using	NULL
an	NULL
expression	NULL
vector	NULL
for	NULL
the	NULL
PC-PLC	NULL
from	NULL
B.	NULL
cereus	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
this	NULL
enzyme	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
clear	NULL
and	NULL
enhancer-dependent	NULL
transactivation	NULL
of	NULL
the	NULL
<	NULL
B-CONA-Luc	NULL
vector	NULL
in	NULL
transient	NULL
cotransfection	NULL
assays	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
these	NULL
experiments	NULL
the	NULL
level	NULL
of	NULL
transactivation	NULL
of	NULL
xB-CONA-Luc	NULL
obtained	NULL
by	NULL
cotransfection	NULL
of	NULL
the	NULL
PC-PLC	NULL
expression	NULL
vector	NULL
was	NULL
not	NULL
further	NULL
modified	NULL
by	NULL
exogenously	NULL
added	NULL
PC-PLC	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
HIV	NULL
enhancer	NULL
transactivation	NULL
induced	NULL
by	NULL
PC-PLC	NULL
resulted	NULL
in	NULL
augmented	NULL
HIV	NULL
genome	NULL
transcription	NULL
and	NULL
virus	NULL
production	NULL
,	NULL
we	NULL
induced	NULL
hydrolysis	NULL
of	NULL
PC	NULL
in	NULL
three	NULL
different	NULL
cell	NULL
lines	NULL
(	NULL
U1	NULL
,	NULL
ACH2	NULL
,	NULL
and	NULL
SPBenv-	NULL
)	NULL
harboring	NULL
integrated	NULL
and	NULL
replicative	NULL
HIV	NULL
provirus	NULL
.	NULL

Results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
demonstrate	NULL
that	NULL
PC-PLC	NULL
treatment	NULL
of	NULL
U1	NULL
,	NULL
a	NULL
monocytic	NULL
cell	NULL
line	NULL
,	NULL
or	NULL
ACH2	NULL
,	NULL
a	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
,	NULL
consistently	NULL
led	NULL
to	NULL
enhanced	NULL
levels	NULL
of	NULL
p24	NULL
Gag	NULL
antigen	NULL
in	NULL
cell	NULL
supernatants	NULL
,	NULL
which	NULL
correlated	NULL
well	NULL
with	NULL
the	NULL
levels	NULL
of	NULL
HIV	NULL
LTR	NULL
transactivation	NULL
promoted	NULL
by	NULL
PC-PLC	NULL
in	NULL
control	NULL
monocytic	NULL
or	NULL
lymphocytic	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
the	NULL
enhanced	NULL
production	NULL
13.7X	NULL
soo7|	NULL
U937	NULL
200	NULL
-	NULL
HIV-LTR-Luc	NULL
El	NULL
HIV-LTRAKB-Luc	NULL
100	NULL
40	NULL
4	NULL
|	NULL
J.	NULL
Jhan	NULL
3.5	NULL
%	NULL
3.3	NULL
%	NULL
I	NULL
HIV-LTR-Lue	NULL
D	NULL
HIV-AkB-Luc	NULL
Luciferase	NULL
activity	NULL
/	NULL
ug	NULL
protein	NULL
(	NULL
RLU	NULL
)	NULL
s	NULL
[	NULL
Q	NULL
kp-conta-Lue	NULL
CONA-Lue	NULL
60	NULL
1|	NULL
NIH3T3	NULL
Pomme	NULL
Inducers	NULL
TNF	NULL
none	NULL
PC-PLC	NULL
none	NULL
PCG-PLC	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Addition	NULL
of	NULL
exogenous	NULL
PC-PLC	NULL
induces	NULL
transcription	NULL
activity	NULL
of	NULL
transfected	NULL
HIV	NULL
LTR	NULL
and	NULL
«	NULL
B	NULL
enhancer-directed	NULL
luciferase	NULL
expression	NULL
vectors	NULL
in	NULL
U937	NULL
,	NULL
J.	NULL
Jhan	NULL
,	NULL
and	NULL
NIH	NULL
3T3	NULL
cells	NULL
.	NULL

Fold	NULL
amplification	NULL
is	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
each	NULL
bar	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
for	NULL
each	NULL
cell	NULL
line	NULL
.	NULL

RLU	NULL
,	NULL
relative	NULL
luciferase	NULL
activity	NULL
units	NULL
.	NULL

6600	NULL
ARENZANA-SEISDEDOS	NULL
ET	NULL
AL	NULL
.	NULL

TABLE	NULL
1	NULL
.	NULL

Phospholipid	NULL
turnover	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
PC-PLC	NULL
Phospholipid	NULL
level	NULL
``	NULL
(	NULL
%	NULL
of	NULL
control	NULL
)	NULL
Cells	NULL
PC-PLC	NULL
PC	NULL
PE	NULL
PS	NULL
SM	NULL
PIPs	NULL
U937	NULL
-	NULL
100	NULL
100	NULL
100	NULL
100	NULL
100	NULL
+	NULL
74	NULL
+	NULL
3	NULL
94	NULL
#	NULL
3	NULL
98	NULL
+2	NULL
100	NULL
+3	NULL
100	NULL
£	NULL
4	NULL
J.	NULL
Jhan	NULL
-	NULL
100	NULL
100	NULL
100	NULL
100	NULL
100	NULL
+	NULL
75	NULL
x	NULL
2	NULL
98	NULL
£2	NULL
100	NULL
£	NULL
3	NULL
100	NULL
+	NULL
5	NULL
100	NULL
+	NULL
4	NULL
``	NULL
Cells	NULL
were	NULL
labelled	NULL
with	NULL
different	NULL
precursors	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
1	NULL
U	NULL
of	NULL
PC-PLC	NULL
per	NULL
ml	NULL
for	NULL
45	NULL
min	NULL
.	NULL

Control	NULL
values	NULL
(	NULL
in	NULL
disintegrations	NULL
per	NULL
minute	NULL
per	NULL
well	NULL
)	NULL
for	NULL
U937	NULL
cells	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
PC	NULL
510,000	NULL
;	NULL
phosphatidylethanolamine	NULL
(	NULL
PE	NULL
)	NULL
;	NULL
415,000	NULL
;	NULL
phosphatidylserine	NULL
(	NULL
PS	NULL
)	NULL
,	NULL
76,000	NULL
;	NULL
sphingomyelin	NULL
(	NULL
SM	NULL
)	NULL
,	NULL
34,000	NULL
;	NULL
polyphosphoinositides	NULL
(	NULL
PIPs	NULL
)	NULL
,	NULL
130,000	NULL
.	NULL

Control	NULL
values	NULL
for	NULL
J.	NULL
Jhan	NULL
cells	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
PC	NULL
,	NULL
400,000	NULL
;	NULL
PE	NULL
,	NULL
840,000	NULL
;	NULL
PS	NULL
,	NULL
63,000	NULL
;	NULL
SM	NULL
,	NULL
23,000	NULL
;	NULL
PIPs	NULL
,	NULL
112,000.	NULL
of	NULL
extracellular	NULL
p24	NULL
antigen	NULL
in	NULL
PC-PLC-treated	NULL
cells	NULL
correlated	NULL
with	NULL
an	NULL
increased	NULL
detection	NULL
of	NULL
intracellular	NULL
p24	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
rules	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
PC-PLC	NULL
in	NULL
HIV-infected	NULL
cells	NULL
was	NULL
due	NULL
to	NULL
an	NULL
enhanced	NULL
shedding	NULL
of	NULL
virus	NULL
particles	NULL
and	NULL
not	NULL
to	NULL
increased	NULL
expression	NULL
of	NULL
the	NULL
viral	NULL
genome	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
analyze	NULL
the	NULL
role	NULL
of	NULL
PC	NULL
hydrolysis	NULL
in	NULL
the	NULL
reactivation	NULL
of	NULL
HIV	NULL
replication	NULL
in	NULL
normal	NULL
,	NULL
nontransformed	NULL
human	NULL
T	NULL
lymphocytes	NULL
,	NULL
we	NULL
used	NULL
an	NULL
IL-2-dependent	NULL
T-cell	NULL
line	NULL
harboring	NULL
an	NULL
integrated	NULL
HIV	NULL
provirus	NULL
replicating	NULL
at	NULL
very	NULL
low	NULL
levels	NULL
.	NULL

Stimulation	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
PC-PLC	NULL
or	NULL
with	NULL
PMA	NULL
for	NULL
24	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
,	NULL
significantly	NULL
enhanced	NULL
production	NULL
of	NULL
p24	NULL
antigen	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
exogenous	NULL
PC-PLC	NULL
specifically	NULL
hydrolyzes	NULL
PC	NULL
but	NULL
not	NULL
other	NULL
,	NULL
cellular	NULL
phospholipids	NULL
.	NULL

In	NULL
a	NULL
previous	NULL
report	NULL
(	NULL
21	NULL
)	NULL
,	NULL
we	NULL
documented	NULL
that	NULL
addition	NULL
of	NULL
purified	NULL
PC-PLC	NULL
from	NULL
B.	NULL
cereus	NULL
to	NULL
NIH	NULL
3T3	NULL
cells	NULL
activates	NULL
breakdown	NULL
of	NULL
PC	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
significant	NULL
changes	NULL
in	NULL
the	NULL
turnover	NULL
of	NULL
other	NULL
phospholipids	NULL
.	NULL

Results	NULL
given	NULL
in	NULL
Table	NULL
1	NULL
show	NULL
that	NULL
a	NULL
similar	NULL
phenomenon	NULL
occurred	NULL
in	NULL
J.	NULL
Jhan	NULL
and	NULL
U937	NULL
cells	NULL
treated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
1	NULL
U	NULL
of	NULL
PC-PLC	NULL
per	NULL
ml	NULL
.	NULL

Indeed	NULL
,	NULL
under	NULL
these	NULL
experimental	NULL
conditions	NULL
a	NULL
clear	NULL
effect	NULL
on	NULL
PC	NULL
metabolism	NULL
was	NULL
observed	NULL
without	NULL
modifications	NULL
of	NULL
the	NULL
sphingomyelin	NULL
or	NULL
PI	NULL
turnover	NULL
.	NULL

Very	NULL
modest	NULL
modifications	NULL
of	NULL
the	NULL
hydrolysis	NULL
of	NULL
phosphatidylserine	NULL
or	NULL
phosphatidylethanol	NULL
were	NULL
detected	NULL
.	NULL

Concomitant	NULL
with	NULL
the	NULL
hydrolysis	NULL
of	NULL
PC	NULL
,	NULL
a	NULL
dramatic	NULL
and	NULL
prompt	NULL
increase	NULL
in	NULL
DAG	NULL
levels	NULL
was	NULL
observed	NULL
in	NULL
U937	NULL
cells	NULL
treated	NULL
with	NULL
PC-PLC	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
.	NULL

Classical	NULL
,	NULL
PMA-inducible	NULL
PKC	NULL
a	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
are	NULL
not	NULL
involved	NULL
in	NULL
the	NULL
transduction	NULL
of	NULL
PC-PLC-induced	NULL
activation	NULL
of	NULL
NF-KB	NULL
and	NULL
HIV	NULL
genome	NULL
transcription	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
NF-kB	NULL
nuclear	NULL
translocation	NULL
induced	NULL
by	NULL
PC-PLC	NULL
requires	NULL
activation	NULL
of	NULL
PMA-inducible	NULL
PKC	NULL
isoforms	NULL
,	NULL
we	NULL
stimulated	NULL
U937	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GF	NULL
,	NULL
a	NULL
potent	NULL
and	NULL
highly	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
«	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
PKC	NULL
isoforms	NULL
.	NULL

Figure	NULL
2	NULL
shows	NULL
that	NULL
2.5	NULL
wM	NULL
GF	NULL
did	NULL
not	NULL
impair	NULL
induction	NULL
of	NULL
nuclear	NULL
NF-kB	NULL
complexes	NULL
by	NULL
PC-PLC	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
lack	NULL
of	NULL
inhibitory	NULL
effect	NULL
of	NULL
GF	NULL
on	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
transactivation	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
and	NULL
induction	NULL
of	NULL
HIV	NULL
replication	NULL
were	NULL
unaffected	NULL
by	NULL
this	NULL
compound	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
failure	NULL
of	NULL
GF	NULL
to	NULL
block	NULL
activation	NULL
by	NULL
PC-PLC	NULL
was	NULL
not	NULL
due	NULL
to	NULL
lack	NULL
of	NULL
effect	NULL
of	NULL
this	NULL
inhibitor	NULL
on	NULL
its	NULL
targets	NULL
,	NULL
since	NULL
GF	NULL
abolished	NULL
induction	NULL
of	NULL
both	NULL
LTR	NULL
transactivation	NULL
and	NULL
viral	NULL
replication	NULL
induced	NULL
by	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Activation	NULL
of	NULL
the	NULL
PC	NULL
turnover	NULL
by	NULL
exogenous	NULL
PC-PLC	NULL
was	NULL
shown	NULL
to	NULL
induce	NULL
a	NULL
clear	NULL
expression	NULL
of	NULL
nuclear	NULL
kB-binding	NULL
J.	NULL
ViroL	NULL
.	NULL

6x10	NULL
7	NULL
sx10°	NULL
|	NULL
5	NULL
4	NULL
4x10	NULL
{	NULL
sx10°	NULL
J	NULL
210°	NULL
{	NULL
32	NULL
CPM	NULL
_	NULL
P-PHOSPHATIDIC	NULL
ACID	NULL
/2X10	NULL
CELLS	NULL
10°	NULL
~	NULL
Inducers	NULL
none	NULL
PC-PLC	NULL
PEPLC	NULL
none	NULL
Incubation	NULL
30°	NULL
60°	NULL
Time	NULL
100	NULL
7	NULL
15.7	NULL
%	NULL
®	NULL
ws	NULL
l	NULL
i	NULL
1X	NULL
Luciferase	NULL
activity	NULL
/	NULL
ug	NULL
protein	NULL
(	NULL
RLU	NULL
)	NULL
1	NULL
U	NULL
Inducers	NULL
none	NULL
TNF	NULL
PC-PLC	NULL
P-PLC	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Production	NULL
of	NULL
DAG	NULL
by	NULL
PC-	NULL
or	NULL
PI-PLC-treated	NULL
U937	NULL
cells	NULL
and	NULL
comparative	NULL
analyses	NULL
of	NULL
the	NULL
abilities	NULL
of	NULL
the	NULL
two	NULL
phosphodiesterases	NULL
to	NULL
induce	NULL
the	NULL
transactivation	NULL
of	NULL
a	NULL
kB-directed	NULL
vector	NULL
.	NULL

(	NULL
a	NULL
)	NULL
U937	NULL
cells	NULL
were	NULL
induced	NULL
with	NULL
1	NULL
U	NULL
of	NULL
either	NULL
PC-PLC	NULL
or	NULL
PI-PLC	NULL
per	NULL
ml	NULL
for	NULL
30	NULL
or	NULL
60	NULL
min	NULL
.	NULL

The	NULL
production	NULL
of	NULL
DAG	NULL
in	NULL
picomoles	NULL
is	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
each	NULL
bar	NULL
.	NULL

(	NULL
b	NULL
)	NULL
After	NULL
42	NULL
h	NULL
of	NULL
transfection	NULL
of	NULL
U937	NULL
cells	NULL
with	NULL
the	NULL
xB-CONA-Luc	NULL
expression	NULL
vector	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
6	NULL
additional	NULL
h	NULL
with	NULL
PC-PLC	NULL
or	NULL
PI-PLC	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
U/ml	NULL
.	NULL

RLU	NULL
,	NULL
relative	NULL
luciferase	NULL
activity	NULL
units	NULL
.	NULL

activity	NULL
in	NULL
human	NULL
monocytes	NULL
and	NULL
T	NULL
lymphocytes	NULL
and	NULL
also	NULL
murine	NULL
NIH	NULL
3T3	NULL
fibroblasts	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
a	NULL
recent	NULL
report	NULL
(	NULL
32	NULL
)	NULL
suggesting	NULL
that	NULL
TNF-induced	NULL
PC-PLC	NULL
activity	NULL
activates	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
and	NULL
our	NULL
previous	NULL
observation	NULL
that	NULL
expression	NULL
of	NULL
activated	NULL
p21ras	NULL
,	NULL
an	NULL
inducer	NULL
of	NULL
PC	NULL
breakdown	NULL
(	NULL
20	NULL
,	NULL
28	NULL
)	NULL
,	NULL
activates	NULL
the	NULL
HIV	NULL
enhancer	NULL
in	NULL
human	NULL
cells	NULL
(	NULL
1a	NULL
)	NULL
.	NULL

The	NULL
present	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
two	NULL
different	NULL
,	NULL
highly	NULL
purified	NULL
preparations	NULL
of	NULL
PC-PLC	NULL
,	NULL
one	NULL
commercially	NULL
available	NULL
and	NULL
the	NULL
other	NULL
prepared	NULL
by	NULL
us	NULL
.	NULL

Furthermore	NULL
,	NULL
expression	NULL
of	NULL
a	NULL
transfected	NULL
B.	NULL
cereus	NULL
PC-PLC	NULL
gene	NULL
,	NULL
the	NULL
same	NULL
which	NULL
was	NULL
used	NULL
to	NULL
prepare	NULL
purified	NULL
proteins	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
induce	NULL
transcriptional	NULL
effects	NULL
on	NULL
B-dependent	NULL
genes	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
exogenous	NULL
PC-PLC	NULL
proteins	NULL
.	NULL

It	NULL
should	NULL
be	NULL
stressed	NULL
,	NULL
however	NULL
,	NULL
that	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
does	NULL
not	NULL
always	NULL
result	NULL
in	NULL
functional	NULL
transactivation	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
.	NULL

We	NULL
have	NULL
indeed	NULL
shown	NULL
a	NULL
dissociation	NULL
between	NULL
these	NULL
two	NULL
events	NULL
in	NULL
human	NULL
T-cell	NULL
clones	NULL
(	NULL
15	NULL
)	NULL
.	NULL

We	NULL
here	NULL
Vou	NULL
.	NULL

67	NULL
,	NULL
1993	NULL
300	NULL
D	NULL
CONA-Lue	NULL
5	NULL
I	NULL
kB-CONA-Luc	NULL
«	NULL
l	NULL
&	NULL
C	NULL
£	NULL
@	NULL
®	NULL
g	NULL
200	NULL
&	NULL
a	NULL
Fal	NULL
=	NULL
3	NULL
13	NULL
%	NULL
0	NULL
C	NULL
®	NULL
#	NULL
C	NULL
ks	NULL
&	NULL
100	NULL
O	NULL
a	NULL
_I	NULL
1x	NULL
0	NULL
4	NULL
Co-transfected	NULL
pomy	NULL
pCMV-PLC	NULL
plasmid	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Endogenous	NULL
PC-PLC	NULL
expressed	NULL
from	NULL
a	NULL
cytomegalovirus	NULL
immediate-early	NULL
gene	NULL
promoter-directed	NULL
vector	NULL
induces	NULL
transactivation	NULL
of	NULL
a	NULL
kB	NULL
enhancer	NULL
.	NULL

One	NULL
microgram	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
(	NULL
«	NULL
B-CONA-Luc	NULL
or	NULL
CONA-Luc	NULL
)	NULL
and	NULL
2.5	NULL
ug	NULL
of	NULL
either	NULL
the	NULL
vector	NULL
carrying	NULL
the	NULL
PC-PLC	NULL
gene	NULL
(	NULL
pCMV-PLC	NULL
)	NULL
or	NULL
a	NULL
control	NULL
without	NULL
the	NULL
inserted	NULL
gene	NULL
(	NULL
pCMV	NULL
)	NULL
were	NULL
cotransfected	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
.	NULL

For	NULL
detection	NULL
of	NULL
luciferase	NULL
activity	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
analyzed	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

Fold	NULL
amplification	NULL
is	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
each	NULL
bar	NULL
.	NULL

The	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
cotransfection	NULL
experi-ments	NULL
.	NULL

RLU	NULL
,	NULL
relative	NULL
luciferase	NULL
activity	NULL
units	NULL
.	NULL

show	NULL
that	NULL
PC	NULL
breakdown	NULL
induced	NULL
by	NULL
exogenous	NULL
PC-PLC	NULL
results	NULL
in	NULL
enhanced	NULL
transcription	NULL
of	NULL
luciferase	NULL
vectors	NULL
under	NULL
the	NULL
control	NULL
of	NULL
either	NULL
the	NULL
whole	NULL
(	NULL
U3	NULL
plus	NULL
R	NULL
)	NULL
HIV	NULL
LTR	NULL
or	NULL
synthetic	NULL
oligonucleotides	NULL
with	NULL
«	NULL
B-responsive	NULL
motifs	NULL
cloned	NULL
upstream	NULL
from	NULL
the	NULL
weak	NULL
CONA	NULL
promoter	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
HIV	NULL
LTR	NULL
activity	NULL
by	NULL
PC-PLC	NULL
correlated	NULL
with	NULL
detection	NULL
of	NULL
bona	NULL
fide	NULL
NF-xB	NULL
complexes	NULL
in	NULL
EMSA	NULL
using	NULL
the	NULL
HIV	NULL
enhancer	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Moreover	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
two	NULL
NF-	NULL
«	NULL
xB-responsive	NULL
motifs	NULL
in	NULL
the	NULL
HIV	NULL
LTR	NULL
abolished	NULL
responsiveness	NULL
to	NULL
exogenous	NULL
PC-PLC	NULL
.	NULL

To	NULL
investigate	NULL
this	NULL
phenomenon	NULL
under	NULL
conditions	NULL
as	NULL
relevant	NULL
as	NULL
possible	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
AIDS	NULL
,	NULL
we	NULL
generated	NULL
an	NULL
appropriate	NULL
cell	NULL
system	NULL
consisting	NULL
of	NULL
a	NULL
CD4-positive	NULL
,	NULL
IL-2-dependent	NULL
human	NULL
T-cell	NULL
clone	NULL
stably	NULL
transfected	NULL
with	NULL
an	NULL
infectious	NULL
HIV-1	NULL
provirus	NULL
clone	NULL
.	NULL

The	NULL
constitutive	NULL
transcriptional	NULL
activity	NULL
of	NULL
this	NULL
integrated	NULL
provirus	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
upregulated	NULL
by	NULL
addition	NULL
in	NULL
the	NULL
culture	NULL
medium	NULL
of	NULL
PC-PLC	NULL
.	NULL

Thus	NULL
,	NULL
PC-PLC-inducible	NULL
transduction	NULL
pathways	NULL
can	NULL
activate	NULL
HIV	NULL
transcription	NULL
in	NULL
normal	NULL
,	NULL
nontransformed	NULL
T	NULL
cells	NULL
under	NULL
conditions	NULL
likely	NULL
to	NULL
mimic	NULL
HIV	NULL
reactivation	NULL
from	NULL
quiescence	NULL
in	NULL
circulating	NULL
T	NULL
cells	NULL
.	NULL

PC-PLC	NULL
clearly	NULL
induced	NULL
functional	NULL
nuclear	NULL
bona	NULL
fide	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
in	NULL
monocytes	NULL
,	NULL
T	NULL
lymphocytes	NULL
,	NULL
and	NULL
fibroblasts	NULL
.	NULL

Con-comitantly	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
p50/p65	NULL
heterodimers	NULL
,	NULL
a	NULL
significant	NULL
increase	NULL
of	NULL
homodimeric	NULL
p50	NULL
complexes	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
U937	NULL
and	NULL
NIH	NULL
3T3	NULL
treated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
EMSA	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
detected	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
PHOSPHATIDYLCHOLINE	NULL
HYDROLYSIS	NULL
INDUCES	NULL
HIV	NULL
REPLICATION	NULL
6601	NULL
U1	NULL
42.2	NULL
%	NULL
4	NULL
10	NULL
.\\\\\\\\\\\\\_\	NULL
N	NULL
N	NULL
N	NULL
1o3	NULL
N	NULL
1x	NULL
N	NULL
N	NULL
N	NULL
N	NULL
N	NULL
N	NULL
10	NULL
*	NULL
P	NULL
6	NULL
none	NULL
10	NULL
7	NULL
a	NULL
ACH2	NULL
~~	NULL
10	NULL
3	NULL
er	NULL
Q.	NULL
Nes	NULL
?	NULL

Q	NULL
4	NULL
N	NULL
a	NULL
10	NULL
.	NULL

1	NULL
%	NULL
N	NULL
a	NULL
{	NULL
>	NULL
R	NULL
3	NULL
N	NULL
-C	NULL
10	NULL
P	NULL
none	NULL
50	NULL
cell	NULL
clone	NULL
491	NULL
|	NULL
(	NULL
SPBenv-	NULL
)	NULL
30	NULL
4	NULL
3.3X	NULL
20	NULL
4	NULL
1	NULL
%	NULL
107	NULL
[	NULL
ﬂ	NULL
0	NULL
none	NULL
PMA	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Exogenous	NULL
PC-PLC	NULL
induces	NULL
HIV	NULL
replication	NULL
in	NULL
chronically	NULL
infected	NULL
monocytes	NULL
and	NULL
T	NULL
lymphocytes	NULL
.	NULL

SPBenv-	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
2	NULL
x	NULL
10°/ml	NULL
for	NULL
24	NULL
h	NULL
after	NULL
being	NULL
cultured	NULL
for	NULL
18	NULL
h	NULL
in	NULL
an	NULL
IL-2-starved	NULL
culture	NULL
medium	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
production	NULL
of	NULL
p24	NULL
,	NULL
culture	NULL
supernatants	NULL
were	NULL
harvested	NULL
after	NULL
24	NULL
h	NULL
of	NULL
induction	NULL
.	NULL

At	NULL
least	NULL
two	NULL
independent	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
each	NULL
cell	NULL
line	NULL
.	NULL

Fold	NULL
amplification	NULL
of	NULL
p24	NULL
production	NULL
with	NULL
respect	NULL
to	NULL
uninduced	NULL
cultures	NULL
is	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
each	NULL
bar	NULL
.	NULL

PC-PLC-treated	NULL
U937	NULL
cells	NULL
indicated	NULL
that	NULL
they	NULL
were	NULL
made	NULL
mainly	NULL
of	NULL
p50/p65	NULL
heterodimers	NULL
and	NULL
p50	NULL
homodimers	NULL
,	NULL
as	NULL
their	NULL
binding	NULL
to	NULL
«	NULL
B	NULL
oligonucleotides	NULL
was	NULL
upshifted	NULL
by	NULL
either	NULL
antibodies	NULL
to	NULL
p50	NULL
or	NULL
those	NULL
to	NULL
p65	NULL
but	NULL
not	NULL
by	NULL
an	NULL
anti-c-Rel	NULL
antibody	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
anti-p50	NULL
antibodies	NULL
,	NULL
which	NULL
promote	NULL
a	NULL
clear	NULL
inhibition	NULL
and	NULL
mobility	NULL
retardation	NULL
of	NULL
both	NULL
homodimeric	NULL
and	NULL
heterodimeric	NULL
complexes	NULL
in	NULL
U937	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
addition	NULL
of	NULL
anti-p65	NULL
exclusively	NULL
retarded	NULL
the	NULL
migration	NULL
of	NULL
heterodimeric	NULL
complexes	NULL
,	NULL
leaving	NULL
unchanged	NULL
the	NULL
binding	NULL
of	NULL
p50	NULL
homodimers	NULL
(	NULL
faster-migrating	NULL
complexes	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
our	NULL
conclusion	NULL
that	NULL
the	NULL
more	NULL
slowly	NULL
migrating	NULL
complexes	NULL
induced	NULL
by	NULL
PC-PLC	NULL
are	NULL
composed	NULL
mainly	NULL
of	NULL
p50/p65	NULL
heterodimers	NULL
is	NULL
reinforced	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
recombinant	NULL
IxB/	NULL
MAD3	NULL
to	NULL
prevent	NULL
their	NULL
binding	NULL
to	NULL
the	NULL
radiolabelled	NULL
probes	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
IxB	NULL
is	NULL
underlined	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
its	NULL
addition	NULL
to	NULL
nuclear	NULL
extracts	NULL
did	NULL
not	NULL
substantially	NULL
modify	NULL
the	NULL
binding	NULL
of	NULL
p50	NULL
homodimers	NULL
(	NULL
faster-migrating	NULL
complexes	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
U937	NULL
and	NULL
NIH	NULL
3T3	NULL
cells	NULL
)	NULL
.	NULL

6602	NULL
ARENZANA-SEISDEDOS	NULL
ET	NULL
AL	NULL
.	NULL

S	NULL
ILL	NULL
L4	NULL
P	NULL
f	NULL
Cota	NULL
¢	NULL
_	NULL
Luciferase	NULL
activity	NULL
/	NULL
ug	NULL
protein	NULL
(	NULL
RLU	NULL
)	NULL
Rs	NULL
I	NULL
A	NULL
e	NULL
HIV-p24	NULL
protein	NULL
(	NULL
pg	NULL
/	NULL
m1	NULL
)	NULL
103	NULL
102	NULL
Inducers	NULL
none	NULL
__	NULL
TNF	NULL
__	NULL
PMA	NULL
ory	NULL
PKC	NULL
_	NULL
inhibitor	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Inducibility	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
and	NULL
HIV	NULL
replication	NULL
by	NULL
PC-PLC	NULL
are	NULL
not	NULL
mediated	NULL
by	NULL
classical	NULL
,	NULL
PMA-inducible	NULL
PKC	NULL
a	NULL
,	NULL
B	NULL
,	NULL
or	NULL
y.	NULL
U937	NULL
cells	NULL
were	NULL
transfected	NULL
for	NULL
42	NULL
h	NULL
with	NULL
the	NULL
HIV-LTR-Luc	NULL
vector	NULL
and	NULL
then	NULL
were	NULL
preincubated	NULL
for	NULL
45	NULL
min	NULL
with	NULL
2.5	NULL
M	NULL
PKC	NULL
inhibitor	NULL
GF	NULL
and	NULL
subsequently	NULL
stimulated	NULL
for	NULL
6	NULL
additional	NULL
h	NULL
with	NULL
PC-PLC	NULL
,	NULL
TNF	NULL
,	NULL
or	NULL
PMA	NULL
.	NULL

U1	NULL
cells	NULL
were	NULL
induced	NULL
for	NULL
24	NULL
h	NULL
with	NULL
the	NULL
same	NULL
inducers	NULL
.	NULL

GF	NULL
was	NULL
added	NULL
45	NULL
min	NULL
before	NULL
induction	NULL
.	NULL

Production	NULL
of	NULL
p24	NULL
was	NULL
evaluated	NULL
in	NULL
culture	NULL
supernatants	NULL
harvested	NULL
24	NULL
h	NULL
after	NULL
induction	NULL
.	NULL

RLU	NULL
,	NULL
relative	NULL
luciferase	NULL
activity	NULL
units	NULL
.	NULL

PC-PLC	NULL
-	NULL
none	NULL
__	NULL
TNF	NULL
PMA	NULL
_	NULL
PC-PLC	NULL
_	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Addition	NULL
of	NULL
exogenous	NULL
PC-PLC	NULL
from	NULL
the	NULL
same	NULL
source	NULL
as	NULL
that	NULL
used	NULL
in	NULL
this	NULL
study	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
promote	NULL
DNA	NULL
synthesis	NULL
and	NULL
cell	NULL
proliferation	NULL
in	NULL
fibroblasts	NULL
(	NULL
21	NULL
)	NULL
.	NULL

We	NULL
now	NULL
show	NULL
that	NULL
exogenous	NULL
PC-PLC	NULL
enhances	NULL
the	NULL
activity	NULL
of	NULL
«	NULL
B-dependent	NULL
luciferase	NULL
expression	NULL
vectors	NULL
and	NULL
induces	NULL
the	NULL
replication	NULL
of	NULL
integrated	NULL
HIV	NULL
provirus	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
that	NULL
PC-PLC	NULL
would	NULL
act	NULL
through	NULL
transcription	NULL
of	NULL
cellular	NULL
genes	NULL
,	NULL
in	NULL
particular	NULL
that	NULL
of	NULL
cellular	NULL
factors	NULL
known	NULL
to	NULL
induce	NULL
NF-kB	NULL
such	NULL
as	NULL
TNF	NULL
and	NULL
IL-1	NULL
,	NULL
we	NULL
induced	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
blockade	NULL
of	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
does	NULL
not	NULL
prevent	NULL
activation	NULL
of	NULL
NF-kB	NULL
complexes	NULL
in	NULL
PC-PLC-treated	NULL
U937	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
,	NULL
together	NULL
with	NULL
the	NULL
absence	NULL
of	NULL
either	NULL
TNF	NULL
or	NULL
IL-1	NULL
activity	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
PC-PLC-treated	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
autocrine	NULL
secretion	NULL
of	NULL
cytokines	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
induced	NULL
by	NULL
PC-PLC	NULL
.	NULL

PC-derived	NULL
DAG	NULL
is	NULL
known	NULL
to	NULL
be	NULL
a	NULL
pivotal	NULL
,	NULL
long-lasting	NULL
second	NULL
messenger	NULL
in	NULL
cell	NULL
activation	NULL
and	NULL
mitogenesis	NULL
(	NULL
11	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Prolonged	NULL
treatment	NULL
of	NULL
U937	NULL
cells	NULL
with	NULL
PC-PLC	NULL
resulted	NULL
in	NULL
high-level	NULL
production	NULL
of	NULL
DAG	NULL
,	NULL
still	NULL
observed	NULL
1	NULL
h	NULL
after	NULL
induction	NULL
.	NULL

This	NULL
is	NULL
not	NULL
surprising	NULL
,	NULL
since	NULL
we	NULL
have	NULL
previously	NULL
reported	NULL
that	NULL
24	NULL
h	NULL
after	NULL
incubation	NULL
of	NULL
fibroblasts	NULL
with	NULL
PI-PLC	NULL
or	NULL
PC-PLC	NULL
,	NULL
DAG	NULL
production	NULL
remains	NULL
elevated	NULL
(	NULL
9	NULL
)	NULL
.	NULL

We	NULL
compared	NULL
the	NULL
efficiencies	NULL
with	NULL
which	NULL
PC-PLC	NULL
and	NULL
PI-PLC	NULL
induce	NULL
NF-kB	NULL
activation	NULL
and	NULL
DAG	NULL
production	NULL
.	NULL

Both	NULL
enzymes	NULL
in	NULL
J.	NULL
Vigo	NULL
.	NULL

duced	NULL
DAG	NULL
,	NULL
but	NULL
only	NULL
PC-PLC	NULL
activated	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
U937	NULL
monocytic	NULL
cell	NULL
line	NULL
.	NULL

DAG	NULL
production	NULL
induced	NULL
by	NULL
PC-PLC	NULL
was	NULL
usually	NULL
higher	NULL
than	NULL
that	NULL
induced	NULL
by	NULL
PI-PLC	NULL
.	NULL

This	NULL
is	NULL
unlikely	NULL
to	NULL
account	NULL
for	NULL
the	NULL
difference	NULL
in	NULL
activities	NULL
,	NULL
since	NULL
we	NULL
observed	NULL
similar	NULL
differences	NULL
in	NULL
other	NULL
cell	NULL
systems	NULL
(	NULL
8	NULL
)	NULL
,	NULL
despite	NULL
induction	NULL
of	NULL
functional	NULL
effects	NULL
of	NULL
PI-PLC	NULL
such	NULL
as	NULL
p80	NULL
phosphorylation	NULL
or	NULL
PKC	NULL
and	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
downregulation	NULL
(	NULL
9	NULL
)	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
and	NULL
confirm	NULL
here	NULL
that	NULL
PC-PLC	NULL
induces	NULL
hydrolysis	NULL
of	NULL
PC	NULL
but	NULL
very	NULL
few	NULL
,	NULL
if	NULL
any	NULL
,	NULL
modifications	NULL
of	NULL
other	NULL
cellular	NULL
phospholipids	NULL
.	NULL

We	NULL
also	NULL
confirmed	NULL
that	NULL
exogenous	NULL
PI-PLC	NULL
induces	NULL
hydrolysis	NULL
of	NULL
PI	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

If	NULL
DAG	NULL
production	NULL
indeed	NULL
has	NULL
a	NULL
role	NULL
in	NULL
the	NULL
transduction	NULL
pathways	NULL
elicited	NULL
by	NULL
exogenous	NULL
PC-PLC	NULL
and	NULL
leading	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
two	NULL
alternative	NULL
explanations	NULL
are	NULL
possible	NULL
.	NULL

One	NULL
is	NULL
that	NULL
molecular	NULL
forms	NULL
of	NULL
DAG	NULL
induced	NULL
by	NULL
the	NULL
two	NULL
enzymes	NULL
are	NULL
functionally	NULL
different	NULL
.	NULL

The	NULL
other	NULL
is	NULL
that	NULL
PC-PLC	NULL
,	NULL
but	NULL
not	NULL
PI-PLC	NULL
,	NULL
induces	NULL
in	NULL
addition	NULL
to	NULL
DAG	NULL
other	NULL
,	NULL
yet	NULL
uncharacterized	NULL
signals	NULL
that	NULL
function	NULL
independently	NULL
or	NULL
in	NULL
association	NULL
with	NULL
DAG	NULL
to	NULL
ultimately	NULL
activate	NULL
NF-kB	NULL
.	NULL

It	NULL
was	NULL
recently	NULL
reported	NULL
that	NULL
addition	NULL
of	NULL
synthetic	NULL
forms	NULL
of	NULL
DAG	NULL
induces	NULL
sphingomyelinase	NULL
activity	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
would	NULL
be	NULL
responsible	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
32	NULL
)	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
,	NULL
however	NULL
,	NULL
that	NULL
we	NULL
could	NULL
not	NULL
detect	NULL
sphingomyelin	NULL
breakdown	NULL
after	NULL
PC-PLC	NULL
treatment	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
used	NULL
here	NULL
.	NULL

We	NULL
previously	NULL
demonstrated	NULL
that	NULL
incubation	NULL
of	NULL
fibroblasts	NULL
with	NULL
PC-PLC	NULL
induces	NULL
PKC	NULL
translocation	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activation	NULL
induced	NULL
by	NULL
PC-PLC	NULL
could	NULL
not	NULL
,	NULL
in	NULL
the	NULL
present	NULL
study	NULL
,	NULL
be	NULL
blocked	NULL
by	NULL
GF	NULL
,	NULL
a	NULL
highly	NULL
specific	NULL
inhibitor	NULL
of	NULL
PMA-inducible	NULL
PKC	NULL
isoforms	NULL
,	NULL
including	NULL
a	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
PKCs	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
work	NULL
showing	NULL
that	NULL
PMA-induced	NULL
PKC	NULL
downregulation	NULL
does	NULL
not	NULL
block	NULL
the	NULL
mitogenic	NULL
effect	NULL
of	NULL
exogenous	NULL
PC-PLC	NULL
on	NULL
fibroblasts	NULL
(	NULL
21	NULL
)	NULL
.	NULL

These	NULL
results	NULL
,	NULL
together	NULL
with	NULL
the	NULL
lack	NULL
of	NULL
effect	NULL
of	NULL
PI-PLC	NULL
,	NULL
a	NULL
known	NULL
inducer	NULL
of	NULL
PMA-inducible	NULL
PKCs	NULL
(	NULL
8	NULL
)	NULL
,	NULL
suggest	NULL
that	NULL
the	NULL
«	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
isoforms	NULL
of	NULL
PKC	NULL
do	NULL
not	NULL
mediate	NULL
the	NULL
NF-	NULL
B-activating	NULL
effects	NULL
of	NULL
PC-PLC	NULL
.	NULL

Although	NULL
the	NULL
cascade	NULL
of	NULL
transduction	NULL
events	NULL
induced	NULL
by	NULL
PC-PLC	NULL
and	NULL
resulting	NULL
in	NULL
NF-KB	NULL
activation	NULL
is	NULL
not	NULL
yet	NULL
characterized	NULL
for	NULL
mammalian	NULL
cells	NULL
,	NULL
an	NULL
exciting	NULL
possibility	NULL
is	NULL
that	NULL
a	NULL
new	NULL
isoform	NULL
of	NULL
PKC	NULL
,	NULL
{	NULL
,	NULL
has	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
this	NULL
cascade	NULL
,	NULL
integrating	NULL
and	NULL
transducing	NULL
the	NULL
signals	NULL
induced	NULL
by	NULL
PC-PLC	NULL
.	NULL

Indeed	NULL
,	NULL
recent	NULL
data	NULL
from	NULL
our	NULL
laboratory	NULL
(	NULL
10	NULL
)	NULL
,	NULL
obtained	NULL
with	NULL
specific	NULL
inhibitory	NULL
peptides	NULL
(	NULL
pseudosubstrates	NULL
)	NULL
,	NULL
show	NULL
that	NULL
{	NULL
,	NULL
but	NULL
not	NULL
«	NULL
,	NULL
PKC	NULL
mediates	NULL
the	NULL
functional	NULL
activation	NULL
of	NULL
NF-kB	NULL
induced	NULL
by	NULL
microinjection	NULL
of	NULL
either	NULL
p21ras	NULL
or	NULL
PC-PLC	NULL
proteins	NULL
into	NULL
Xenopus	NULL
oocytes	NULL
.	NULL

Recent	NULL
results	NULL
(	NULL
9a	NULL
)	NULL
in	NULL
our	NULL
laboratory	NULL
are	NULL
compatible	NULL
with	NULL
this	NULL
hypothesis	NULL
,	NULL
since	NULL
cells	NULL
expressing	NULL
consti-tutively	NULL
high	NULL
levels	NULL
of	NULL
{	NULL
PKC	NULL
show	NULL
permanent	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
binding	NULL
activity	NULL
.	NULL

An	NULL
original	NULL
cellular	NULL
transduction	NULL
pathway	NULL
generated	NULL
by	NULL
cell	NULL
membrane	NULL
signalling	NULL
and	NULL
involving	NULL
p21ras	NULL
activation	NULL
,	NULL
PC	NULL
breakdown	NULL
,	NULL
and	NULL
{	NULL
PKC	NULL
induction	NULL
may	NULL
thus	NULL
be	NULL
envisaged	NULL
.	NULL

This	NULL
pathway	NULL
might	NULL
be	NULL
used	NULL
by	NULL
all	NULL
membrane	NULL
signals	NULL
which	NULL
can	NULL
induce	NULL
PC	NULL
breakdown	NULL
.	NULL

This	NULL
is	NULL
the	NULL
case	NULL
with	NULL
CD3	NULL
stimulation	NULL
(	NULL
34	NULL
)	NULL
,	NULL
TNF	NULL
(	NULL
31	NULL
)	NULL
,	NULL
IL-1	NULL
(	NULL
29	NULL
)	NULL
,	NULL
and	NULL
even	NULL
PMA	NULL
stimulation	NULL
,	NULL
which	NULL
,	NULL
through	NULL
cross-talk	NULL
,	NULL
can	NULL
induce	NULL
PC	NULL
hydrolysis	NULL
(	NULL
6	NULL
,	NULL
23	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
sphingomyelinase	NULL
activation	NULL
and	NULL
ceramide	NULL
production	NULL
can	NULL
not	NULL
account	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
all	NULL
these	NULL
inducers	NULL
,	NULL
since	NULL
stimulation	NULL
of	NULL
the	NULL
EL4	NULL
T-cell	NULL
line	NULL
through	NULL
CD3	NULL
or	NULL
by	NULL
PMA	NULL
,	NULL
which	NULL
induces	NULL
intense	NULL
NF-	NULL
«	NULL
B-dependent	NULL
HIV	NULL
LTR	NULL
transactivation	NULL
(	NULL
12a	NULL
)	NULL
,	NULL
does	NULL
not	NULL
elicit	NULL
a	NULL
ceramide	NULL
response	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
PC	NULL
breakdown	NULL
triggered	NULL
on	NULL
the	NULL
occasion	NULL
of	NULL
T-cell	NULL
and	NULL
macrophage	NULL
activation	NULL
by	NULL
physiological	NULL
inducers	NULL
may	NULL
have	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
HIV	NULL
replication	NULL
.	NULL

In	NULL
monocytes	NULL
,	NULL
HIV	NULL
replication	NULL
itself	NULL
induces	NULL
,	NULL
in	NULL
an	NULL
o-	NULL
,	NULL
B-	NULL
,	NULL
and	NULL
y-PKC-independent	NULL
manner	NULL
sustained	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
responsible	NULL
for	NULL
self-perpetuating	NULL
HIV	NULL
enhancer	NULL
activity	NULL
(	NULL
2	NULL
,	NULL
27	NULL
)	NULL
.	NULL

The	NULL
characterization	NULL
of	NULL
a	NULL
transduction	NULL
pathway	NULL
Vor	NULL
.	NULL

67	NULL
,	NULL
1993	NULL
PHOSPHATIDYLCHOLINE	NULL
HYDROLYSIS	NULL
INDUCES	NULL
HIV	NULL
REPLICATION	NULL
6603	NULL
controlling	NULL
HIV	NULL
genome	NULL
transcription	NULL
,	NULL
induced	NULL
by	NULL
physiological	NULL
cell	NULL
signalling	NULL
and	NULL
possibly	NULL
by	NULL
HIV	NULL
replication	NULL
itself	NULL
,	NULL
offers	NULL
potential	NULL
cellular	NULL
targets	NULL
for	NULL
antiviral	NULL
intervention	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
are	NULL
indebted	NULL
to	NULL
S.	NULL
Michelson	NULL
and	NULL
A.	NULL
Garcia	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
funds	NULL
of	NULL
Agence	NULL
Nationale	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
le	NULL
SIDA	NULL
(	NULL
France	NULL
)	NULL
and	NULL
by	NULL
grants	NULL
SAL-90-0070	NULL
and	NULL
PTR	NULL
91-0022	NULL
from	NULL
Comision	NULL
Interministerial	NULL
de	NULL
Ciencia	NULL
y	NULL
Tecnologia	NULL
and	NULL
PB90.0074	NULL
from	NULL
Direccion	NULL
General	NULL
de	NULL
Investigacion	NULL
Cientifica	NULL
y	NULL
Tecnologica	NULL
(	NULL
Spain	NULL
)	NULL
.	NULL

BF	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
a	NULL
fellowship	NULL
from	NULL
the	NULL
European	NULL
Communities	NULL
.	NULL

LD	NULL
.	NULL

and	NULL
M.T.D-M.	NULL
are	NULL
fellows	NULL
of	NULL
Gobierno	NULL
Vasco	NULL
and	NULL
Ministerio	NULL
de	NULL
Educacion	NULL
(	NULL
Spain	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Arenzana-Seisdedos	NULL
,	NULL
F.	NULL
Unpublished	NULL
data	NULL
.	NULL

la	NULL
.	NULL

Arenzana-Seisdedos	NULL
,	NULL
F.	NULL
,	NULL
N.	NULL
Israél	NULL
,	NULL
F.	NULL
Bachelerie	NULL
,	NULL
U.	NULL
Hazan	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
F.	NULL
Dautry	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Virelizier	NULL
.	NULL

1989.	NULL
c-Ha-ras	NULL
transfection	NULL
induces	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
transcription	NULL
through	NULL
the	NULL
HIV-enhancer	NULL
in	NULL
human	NULL
fibroblasts	NULL
and	NULL
astrocytes	NULL
.	NULL

Oncogene	NULL
2:1359-1362.	NULL
.	NULL

Bachelerie	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Virelizier	NULL
.	NULL

1991	NULL
.	NULL

HIV	NULL
enhancer	NULL
activity	NULL
perpetuated	NULL
by	NULL
NF-kB	NULL
induction	NULL
on	NULL
infection	NULL
of	NULL
monocytes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
350:709-712	NULL
.	NULL

3	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

IxB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-kB	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540-546	NULL
.	NULL

4	NULL
.	NULL

Berry	NULL
,	NULL
N.	NULL
,	NULL
K.	NULL
Ase	NULL
,	NULL
A.	NULL
Kishimoto	NULL
,	NULL
and	NULL
Y.	NULL
Nishizuka	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
of	NULL
resting	NULL
human	NULL
T	NULL
cells	NULL
requires	NULL
prolonged	NULL
stimulation	NULL
of	NULL
protein	NULL
kinase	NULL
C.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
,	NULL
USA	NULL
87:2294-2298	NULL
.	NULL

5	NULL
.	NULL

Berry	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Y.	NULL
Nishizuka	NULL
.	NULL

1990	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
and	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

189:205-214	NULL
.	NULL

6	NULL
.	NULL

Besterman	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
V.	NULL
Duronio	NULL
,	NULL
and	NULL
P.	NULL
Cuatrecasas	NULL
.	NULL

1986	NULL
.	NULL

Rapid	NULL
formation	NULL
of	NULL
diacylglycerol	NULL
from	NULL
phosphatidylcholine	NULL
:	NULL
a	NULL
pathway	NULL
for	NULL
generation	NULL
of	NULL
a	NULL
second	NULL
messenger	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83:6785-6789	NULL
.	NULL

7	NULL
.	NULL

Chattopadhyay	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
A.	NULL
I.	NULL
Oliff	NULL
,	NULL
D.	NULL
L.	NULL
Linemeyer	NULL
,	NULL
M.	NULL
R.	NULL
Lander	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Lowry	NULL
.	NULL

1981	NULL
.	NULL

Genomes	NULL
of	NULL
murine	NULL
leukemia	NULL
viruses	NULL
isolated	NULL
from	NULL
wild	NULL
mice	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

39:777-791	NULL
.	NULL

8	NULL
.	NULL

Diaz-Laviada	NULL
,	NULL
I.	NULL
,	NULL
P.	NULL
Larrodera	NULL
,	NULL
M.	NULL
T.	NULL
Diaz-Meco	NULL
,	NULL
M.	NULL
E.	NULL
Cornet	NULL
,	NULL
P.	NULL
E.	NULL
Guddal	NULL
,	NULL
T.	NULL
Johanssen	NULL
,	NULL
and	NULL
J.	NULL
Moscat	NULL
.	NULL

1990	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
role	NULL
of	NULL
phosphatidylcholine-hydrolysing	NULL
phospholipase	NULL
C	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
by	NULL
ras	NULL
and	NULL
src	NULL
oncogenes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:3907-3912	NULL
.	NULL

9	NULL
.	NULL

Diaz-Laviada	NULL
,	NULL
L.	NULL
,	NULL
P.	NULL
Larrodera	NULL
,	NULL
J.	NULL
L.	NULL
Nieto	NULL
,	NULL
M.	NULL
E.	NULL
Cornet	NULL
,	NULL
M.	NULL
T.	NULL
Diaz-Meco	NULL
,	NULL
M.	NULL
J.	NULL
Sanchez	NULL
,	NULL
P.	NULL
H.	NULL
Guddal	NULL
,	NULL
T.	NULL
Johanssen	NULL
,	NULL
A.	NULL
Haro	NULL
,	NULL
and	NULL
J.	NULL
Moscat	NULL
.	NULL

1991	NULL
.	NULL

Mechanism	NULL
of	NULL
inhibition	NULL
of	NULL
adenylate	NULL
cyclase	NULL
by	NULL
phospholipase	NULL
C-catalyzed	NULL
hydrolysis	NULL
of	NULL
phosphatidylcholine	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:1	NULL
170-1176	NULL
.	NULL

9a.Diaz-Meco	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
E.	NULL
Berra	NULL
,	NULL
M.	NULL
M.	NULL
Municio	NULL
,	NULL
L.	NULL
Sanz	NULL
,	NULL
J.	NULL
Lozano	NULL
,	NULL
I.	NULL
Dominguez	NULL
,	NULL
V.	NULL
Diaz-Golpe	NULL
,	NULL
M.	NULL
T.	NULL
Lain	NULL
de	NULL
Lera	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
C.	NULL
V.	NULL
Paya	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
J.	NULL
L.	NULL
Virelizier	NULL
,	NULL
and	NULL
J.	NULL
Moscat	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
dominant	NULL
negative	NULL
protein	NULL
kinase	NULL
C	NULL
{	NULL
subspecies	NULL
blocks	NULL
NF-kB	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:4770-4775	NULL
.	NULL

10	NULL
.	NULL

Dominguez	NULL
,	NULL
L.	NULL
,	NULL
L.	NULL
Sanz	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
M.	NULL
T.	NULL
Diaz-Meco	NULL
,	NULL
J.	NULL
L.	NULL
Virelizier	NULL
,	NULL
and	NULL
J.	NULL
Moscat	NULL
.	NULL

1993	NULL
.	NULL

Inhibition	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
&	NULL
subspecies	NULL
blocks	NULL
the	NULL
activation	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
activity	NULL
in	NULL
Xenopus	NULL
laevis	NULL
oocytes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1290-1295	NULL
.	NULL

11	NULL
.	NULL

Exton	NULL
,	NULL
J.	NULL
H.	NULL
1990	NULL
.	NULL

Signalling	NULL
through	NULL
phosphatidylcholine	NULL
breakdown	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:1-4	NULL
.	NULL

12	NULL
.	NULL

Feinberg	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Frankel	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
role	NULL
of	NULL
tat	NULL
in	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
life	NULL
cycle	NULL
indicates	NULL
a	NULL
primary	NULL
effect	NULL
on	NULL
transcriptional	NULL
elongation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:4045-4049	NULL
.	NULL

12a.Fernandez	NULL
,	NULL
B	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

13	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
in	NULL
vitro	NULL
of	NULL
NF-kappaB	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
inhibitor	NULL
IkappaB	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
334:678-682	NULL
.	NULL

14	NULL
.	NULL

Haseltine	NULL
,	NULL
W.	NULL
1988	NULL
.	NULL

Regulation	NULL
of	NULL
replication	NULL
of	NULL
HIV-1	NULL
,	NULL
p.	NULL
139-158	NULL
.	NULL

In	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
Jt	NULL
.	NULL

,	NULL
B.	NULL
R.	NULL
Cullen	NULL
,	NULL
and	NULL
F.	NULL
Wong-Staal	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

.	NULL

bo	NULL
24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

Control	NULL
of	NULL
human	NULL
retrovirus	NULL
gene	NULL
expression	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
.	NULL

Hazan	NULL
,	NULL
U.	NULL
,	NULL
D.	NULL
Thomas	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
F.	NULL
Bachelerie	NULL
,	NULL
N.	NULL
Israél	NULL
,	NULL
H.	NULL
Yssel	NULL
,	NULL
J.	NULL
L.	NULL
Virelizier	NULL
,	NULL
and	NULL
F.	NULL
Arenzana-Seisdedos	NULL
.	NULL

1990	NULL
.	NULL

Stimulation	NULL
of	NULL
a	NULL
human	NULL
T	NULL
cell	NULL
clone	NULL
with	NULL
anti-CD3	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
induces	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
but	NULL
not	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
1	NULL
enhancer-dependent	NULL
transcription	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:7861-7865.	NULL
.	NULL

Horvat	NULL
,	NULL
R.	NULL
T.	NULL
,	NULL
and	NULL
C.	NULL
Wood	NULL
.	NULL

1989	NULL
.	NULL

HIV	NULL
promoter	NULL
activity	NULL
in	NULL
primary	NULL
antigen	NULL
specific	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

132:2745-2751.	NULL
.	NULL

Israél	NULL
,	NULL
N.	NULL
,	NULL
U.	NULL
Hazan	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
A.	NULL
Munier	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
F.	NULL
Bachelerie	NULL
,	NULL
A.	NULL
Israél	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Virelizier	NULL
.	NULL

1987	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
stimulates	NULL
transcription	NULL
of	NULL
HIV-1	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
,	NULL
independently	NULL
and	NULL
synergistically	NULL
with	NULL
mitogens	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:3956-3960.	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
J.	NULL
Vandekerekhove	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Urban	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
«	NULL
BFI	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007-1018.	NULL
.	NULL

Kimura	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Israél	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
and	NULL
P.	NULL
Kourilsky	NULL
.	NULL

1986	NULL
.	NULL

Detailed	NULL
analysis	NULL
of	NULL
the	NULL
mouse	NULL
H-2	NULL
«	NULL
B	NULL
promoter	NULL
:	NULL
enhancer-like	NULL
sequences	NULL
and	NULL
their	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
class	NULL
gene	NULL
expression	NULL
.	NULL

Cell	NULL
44:261-272.	NULL
.	NULL

Lacal	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
J.	NULL
Moscat	NULL
,	NULL
and	NULL
S.	NULL
A.	NULL
Aaronson	NULL
.	NULL

1987	NULL
.	NULL

Novel	NULL
source	NULL
of	NULL
1.2-diacylglycerol	NULL
elevated	NULL
in	NULL
cells	NULL
transformed	NULL
by	NULL
Ha-ras-onco-gene	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
330:269-272.	NULL
.	NULL

Larrodera	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
E.	NULL
Cornet	NULL
,	NULL
M.	NULL
T.	NULL
Diaz-Meco	NULL
,	NULL
M.	NULL
Lopez-Bara-	NULL
hona	NULL
,	NULL
I.	NULL
Diaz-Laviada	NULL
,	NULL
P.	NULL
E.	NULL
Guddal	NULL
,	NULL
T.	NULL
Johansen	NULL
,	NULL
and	NULL
J.	NULL
Moscat	NULL
.	NULL

1990	NULL
.	NULL

Phospholipase	NULL
C-mediated	NULL
hydrolysis	NULL
of	NULL
phosphatidylcholine	NULL
is	NULL
an	NULL
important	NULL
step	NULL
in	NULL
PDGF-stimulated	NULL
DNA	NULL
synthesis	NULL
.	NULL

Cell	NULL
61:1	NULL
113-1120.	NULL
.	NULL

Liou	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
precursor	NULL
,	NULL
p105	NULL
,	NULL
contains	NULL
an	NULL
internal	NULL
I	NULL
«	NULL
B-like	NULL
inhibitor	NULL
that	NULL
preferentially	NULL
inhibits	NULL
p50	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11	NULL
:	NULL
3003-3009.	NULL
.	NULL

Liscovitch	NULL
,	NULL
M.	NULL
1992	NULL
.	NULL

Crosstalk	NULL
among	NULL
multiple	NULL
signal-activated	NULL
phospholipases	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17:393-399	NULL
.	NULL

Mathias	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
Younes	NULL
,	NULL
C.	NULL
C.	NULL
Kan	NULL
,	NULL
I.	NULL
Orlow	NULL
,	NULL
C.	NULL
Joseph	NULL
,	NULL
and	NULL
R.	NULL
N.	NULL
Kolesnick	NULL
.	NULL

1993	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
sphingomyelin	NULL
signaling	NULL
pathway	NULL
in	NULL
intact	NULL
EL4	NULL
cells	NULL
and	NULL
in	NULL
a	NULL
cell-free	NULL
system	NULL
by	NULL
IL-1b	NULL
.	NULL

Science	NULL
259:519-522	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
1-713	NULL
.	NULL

Ono	NULL
,	NULL
J.	NULL
,	NULL
T.	NULL
Fuji	NULL
,	NULL
K.	NULL
Ogita	NULL
,	NULL
K.	NULL
Kikkawa	NULL
,	NULL
K.	NULL
Igarashi	NULL
,	NULL
and	NULL
Y.	NULL
Nishizuka	NULL
.	NULL

1989	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
{	NULL
subspecies	NULL
from	NULL
rat	NULL
brain	NULL
:	NULL
its	NULL
structure	NULL
,	NULL
expression	NULL
and	NULL
properties	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:3099-3103.	NULL
.	NULL

Paya	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
R.	NULL
M.	NULL
Ten	NULL
,	NULL
C.	NULL
Bessia	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
R.	NULL
T.	NULL
Hay	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Virelizier	NULL
.	NULL

1992	NULL
.	NULL

NF-kB-dependent	NULL
induction	NULL
of	NULL
the	NULL
NF-kB	NULL
p50	NULL
subunit	NULL
underlies	NULL
self-perpetuation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
transcription	NULL
in	NULL
monocyte	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7826-7830	NULL
.	NULL

28	NULL
.	NULL

Price	NULL
,	NULL
B.	NULL
D.	NULL
,	NULL
J.	NULL
D.	NULL
Morris	NULL
,	NULL
C.	NULL
J.	NULL
Marshall	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Hall	NULL
.	NULL

1989	NULL
.	NULL

Stimulation	NULL
of	NULL
phosphatidylcholine	NULL
hydrolysis	NULL
,	NULL
diacylglycerol	NULL
release	NULL
and	NULL
arachidonic	NULL
acid	NULL
production	NULL
by	NULL
oncogenic	NULL
ras	NULL
is	NULL
a	NULL
consequence	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
activation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
:	NULL
16638-16643	NULL
.	NULL

29	NULL
.	NULL

Rossof	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
N.	NULL
Savage	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Dinarello	NULL
.	NULL

1988	NULL
.	NULL

Interleukin	NULL
1	NULL
stimulates	NULL
diacylglycerol	NULL
production	NULL
in	NULL
T	NULL
lymphocytes	NULL
by	NULL
a	NULL
novel	NULL
mechanism	NULL
.	NULL

Cell	NULL
54:73-81	NULL
.	NULL

30	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
J.	NULL
Dillon	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
C.	NULL
H.	NULL
Chen	NULL
,	NULL
M.	NULL
32	NULL
.	NULL

Maher	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
C.	NULL
Rosen	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
rel-related	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
65-Kd	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
251:1490-1493.	NULL
.	NULL

Schiitze	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
Berkovic	NULL
,	NULL
O.	NULL
Tomsing	NULL
,	NULL
C.	NULL
Unger	NULL
,	NULL
and	NULL
M.	NULL
Kronke	NULL
.	NULL

1992	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
induces	NULL
rapid	NULL
production	NULL
of	NULL
1	NULL
'	NULL
2	NULL
'	NULL
diacylglycerol	NULL
by	NULL
a	NULL
phosphatidylcholine-specific	NULL
phospholipase	NULL
C.	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174:975-988	NULL
.	NULL

Schiitze	NULL
,	NULL
S.	NULL
,	NULL
K.	NULL
Posthoff	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
D.	NULL
Berkovic	NULL
,	NULL
K.	NULL
Wiegmann	NULL
,	NULL
and	NULL
M.	NULL
Krinke	NULL
.	NULL

1992	NULL
.	NULL

TNF	NULL
activates	NULL
NF-kB	NULL
by	NULL
phosphatidylIcho-	NULL
6604	NULL
ARENZANA-SEISDEDOS	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

line	NULL
phospholipase	NULL
C-induced	NULL
``	NULL
acidic	NULL
``	NULL
sphingomyeline	NULL
.	NULL

Cell	NULL
71	NULL
:	NULL
35	NULL
.	NULL

Tong-Starksen	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
A.	NULL
Luciw	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Peterlin	NULL
.	NULL

1989	NULL
.	NULL

Hu-	NULL
765-1766.	NULL
man	NULL
immunodeficiency	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
responds	NULL
to	NULL
33	NULL
.	NULL

Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
F.	NULL
Josephs	NULL
,	NULL
M.	NULL
Dukovich	NULL
,	NULL
N.	NULL
Pieffer	NULL
,	NULL
F.	NULL
Wong-	NULL
T	NULL
cell	NULL
activation	NULL
signals	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:7861-	NULL
Staal	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1987	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
HIV-LTR	NULL
by	NULL
T	NULL
7865.	NULL
cell	NULL
mitogens	NULL
and	NULL
the	NULL
trans-activator	NULL
protein	NULL
of	NULL
HTLV-1	NULL
.	NULL

Science	NULL
36	NULL
.	NULL

Toullec	NULL
,	NULL
D.	NULL
,	NULL
H.	NULL
Pianetti	NULL
,	NULL
H.	NULL
Coste	NULL
,	NULL
P.	NULL
Bellevergue	NULL
,	NULL
T.	NULL
Grand-Perret	NULL
,	NULL
238:1575-1578	NULL
.	NULL

M.	NULL
Akajane	NULL
,	NULL
V.	NULL
Baudet	NULL
,	NULL
P.	NULL
Boisson	NULL
,	NULL
E.	NULL
Boursier	NULL
,	NULL
F.	NULL
Loriolle	NULL
,	NULL
L.	NULL
34	NULL
.	NULL

Stewart	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
G.	NULL
Z.	NULL
Cunningham	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Strupp	NULL
,	NULL
F.	NULL
S.	NULL
House	NULL
,	NULL
L.	NULL
L.	NULL
Duhamel	NULL
,	NULL
D.	NULL
Charron	NULL
,	NULL
and	NULL
J.	NULL
Kirilowsky	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
bisindolyl-	NULL
Kelley	NULL
,	NULL
G.	NULL
S.	NULL
Henderson	NULL
,	NULL
J.	NULL
H.	NULL
Exton	NULL
,	NULL
and	NULL
S.	NULL
B.	NULL
Bocckino	NULL
.	NULL

1991.	NULL
maleimide	NULL
GF109203x	NULL
is	NULL
a	NULL
potent	NULL
and	NULL
selective	NULL
inhibitor	NULL
of	NULL
protein	NULL
Activation	NULL
of	NULL
phospholipase	NULL
D	NULL
:	NULL
a	NULL
signaling	NULL
system	NULL
set	NULL
in	NULL
motion	NULL
by	NULL
kinase	NULL
C.	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:15771-15781.	NULL
perturbation	NULL
of	NULL
the	NULL
lymphocyte	NULL
antigen	NULL
receptor/CD3	NULL
complex	NULL
.	NULL

37	NULL
.	NULL

Virelizier	NULL
,	NULL
J.	NULL
L.	NULL
1990	NULL
.	NULL

Cellular	NULL
activation	NULL
and	NULL
human	NULL
immunodefi-	NULL
Cell	NULL
.	NULL

Regul	NULL
.	NULL

2:841-850.	NULL
ciency	NULL
virus	NULL
infection	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

2:409-413	NULL
.	NULL

